BLASTP 2.12.0+


Reference: Stephen F. Altschul, Thomas L. Madden, Alejandro A.
Schaffer, Jinghui Zhang, Zheng Zhang, Webb Miller, and David J.
Lipman (1997), "Gapped BLAST and PSI-BLAST: a new generation of
protein database search programs", Nucleic Acids Res. 25:3389-3402.


Reference for composition-based statistics: Alejandro A. Schaffer,
L. Aravind, Thomas L. Madden, Sergei Shavirin, John L. Spouge, Yuri
I. Wolf, Eugene V. Koonin, and Stephen F. Altschul (2001),
"Improving the accuracy of PSI-BLAST protein database searches with
composition-based statistics and other refinements", Nucleic Acids
Res. 29:2994-3005.



Database: VFDB_setB_pro.fas
           27,982 sequences; 13,298,383 total letters



Query= g2428.t1

Length=391
                                                                      Score     E
Sequences producing significant alignments:                          (Bits)  Value

VFG037711(gb|WP_000010646) (adeF) membrane-fusion protein [AdeFGH...  60.8    5e-10
VFG037714(gb|WP_000010641) (adeF) membrane-fusion protein [AdeFGH...  60.8    5e-10
VFG037709(gb|WP_000010642) (adeF) membrane-fusion protein [AdeFGH...  60.5    5e-10
VFG036987(gb|WP_014582209) (mtrC) membrane fusion protein MtrC [M...  60.5    6e-10
VFG037705(gb|WP_000010636) (adeF) membrane-fusion protein [AdeFGH...  60.5    6e-10
VFG036975(gb|WP_010951249) (mtrC) membrane fusion protein MtrC [M...  60.5    6e-10
VFG037706(gb|YP_001085329) (adeF) membrane-fusion protein [AdeFGH...  60.1    7e-10
VFG036981(gb|WP_002232912) (mtrC) membrane fusion protein MtrC [M...  60.1    8e-10
VFG036984(gb|WP_014580972) (mtrC) membrane fusion protein MtrC [M...  60.1    9e-10
VFG036979(gb|WP_002246382) (mtrC) membrane fusion protein MtrC [M...  60.1    9e-10
VFG036983(gb|WP_002216627) (mtrC) membrane fusion protein MtrC [M...  59.7    9e-10
VFG036980(gb|WP_014573842) (mtrC) membrane fusion protein MtrC [M...  59.7    9e-10
VFG036982(gb|WP_002224350) (mtrC) membrane fusion protein MtrC [M...  59.7    9e-10
VFG036978(gb|WP_004465401) (mtrC) membrane fusion protein MtrC [M...  59.7    1e-09
VFG036976(gb|WP_002220426) (mtrC) membrane fusion protein MtrC [M...  59.3    1e-09
VFG036973(gb|WP_002222106) (mtrC) membrane fusion protein MtrC [M...  58.9    2e-09
VFG036990(gb|WP_013448559) (mtrC) membrane fusion protein MtrC [M...  58.9    2e-09
VFG036974(gb|WP_002224968) (mtrC) membrane fusion protein MtrC [M...  58.9    2e-09
VFG049129(gb|YP_005225489) (acrA) acriflavine resistance protein ...  57.8    4e-09
VFG049125(gb|WP_004136054) (acrA) acriflavine resistance protein ...  57.8    5e-09
VFG049133(gb|WP_004177236) (acrA) acriflavine resistance protein ...  57.4    5e-09
VFG049135(gb|WP_008805438) (acrA) acriflavine resistance protein ...  56.2    1e-08
VFG049128(gb|WP_012542667) (acrA) acriflavine resistance protein ...  56.2    1e-08


>VFG037711(gb|WP_000010646) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii D1279779]
Length=405

 Score = 60.8 bits (146),  Expect = 5e-10, Method: Compositional matrix adjust.
 Identities = 49/178 (28%), Positives = 81/178 (46%), Gaps = 14/178 (8%)

Query  54   GTLQPRRYVDVGAQASGQIRKLHVEAGDDVTEGQLLVEIDPSTQQAKVDAGRYSIEMLKA  113
            G L+    VD+  Q SG++  +H + G  V +G LL  IDP   +A+++         KA
Sbjct  64   GRLEAIDQVDIRPQVSGKLVAVHFKDGSLVKKGDLLFTIDPRPFEAELNRA-------KA  116

Query  114  QLAEQRAQYTLARQQYQRQQRLAAGGATRTEDVQSAQAQMLATQARIEMYQAQIRQAQAS  173
            QLA   AQ T       R QRL    A   +++  A+    +  A ++        A+A+
Sbjct  117  QLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSANANLQA-------ARAA  169

Query  174  LRSDEAELGYTRIYAPMSGTVVAVDAREGQTLNAQQQTPLILRIAKLSPMTVWAQVSE  231
            ++S    L YTRI AP+SG +   +   G  ++A     ++  +  +S +     V E
Sbjct  170  VQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDE  227


>VFG037714(gb|WP_000010641) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii SDF]
Length=405

 Score = 60.8 bits (146),  Expect = 5e-10, Method: Compositional matrix adjust.
 Identities = 49/178 (28%), Positives = 81/178 (46%), Gaps = 14/178 (8%)

Query  54   GTLQPRRYVDVGAQASGQIRKLHVEAGDDVTEGQLLVEIDPSTQQAKVDAGRYSIEMLKA  113
            G L+    VD+  Q SG++  +H + G  V +G LL  IDP   +A+++         KA
Sbjct  64   GRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAELNRA-------KA  116

Query  114  QLAEQRAQYTLARQQYQRQQRLAAGGATRTEDVQSAQAQMLATQARIEMYQAQIRQAQAS  173
            QLA   AQ T       R QRL    A   +++  A+    +  A ++        A+A+
Sbjct  117  QLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSANANLQA-------ARAA  169

Query  174  LRSDEAELGYTRIYAPMSGTVVAVDAREGQTLNAQQQTPLILRIAKLSPMTVWAQVSE  231
            ++S    L YTRI AP+SG +   +   G  ++A     ++  +  +S +     V E
Sbjct  170  VQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDE  227


>VFG037709(gb|WP_000010642) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii BJAB0715]
Length=406

 Score = 60.5 bits (145),  Expect = 5e-10, Method: Compositional matrix adjust.
 Identities = 46/154 (30%), Positives = 73/154 (47%), Gaps = 14/154 (9%)

Query  54   GTLQPRRYVDVGAQASGQIRKLHVEAGDDVTEGQLLVEIDPSTQQAKVDAGRYSIEMLKA  113
            G L+    VD+  Q SG++  +H + G  V +G LL  IDP   +A+++         KA
Sbjct  64   GRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAELNRA-------KA  116

Query  114  QLAEQRAQYTLARQQYQRQQRLAAGGATRTEDVQSAQAQMLATQARIEMYQAQIRQAQAS  173
            QLA   AQ T       R QRL    A   +++  A+    +  A ++        A+A+
Sbjct  117  QLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSANANLQA-------ARAA  169

Query  174  LRSDEAELGYTRIYAPMSGTVVAVDAREGQTLNA  207
            ++S    L YTRI AP+SG +   +   G  ++A
Sbjct  170  VQSARLNLEYTRITAPVSGRISRAEVTVGNVVSA  203


>VFG036987(gb|WP_014582209) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis M01-240355]
Length=412

 Score = 60.5 bits (145),  Expect = 6e-10, Method: Compositional matrix adjust.
 Identities = 61/200 (31%), Positives = 96/200 (48%), Gaps = 15/200 (8%)

Query  39   VSVSRGSIESSVSALGTLQPRRYVDVGAQASGQIRKLHVEAGDDVTEGQLLVEIDPSTQQ  98
            V+V   ++  +V   G L+  R  DV AQ  G I+K   + G  V  GQ L +ID ST +
Sbjct  50   VTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYE  109

Query  99   AKVDAGRYSIEMLKAQLAEQRAQYTLARQQYQRQQRLAAGGATRTEDVQSAQAQMLATQA  158
            A       S+E  +AQLA  +A    A     R + L A  A   ++  +A      T  
Sbjct  110  A-------SLESARAQLATAQATLAKADADLARYKPLVAADAISKQEYDAA-----VTAK  157

Query  159  RIEMYQAQIRQAQASLRSDEAELGYTRIYAPMSGTVVAVDAREGQTLNAQQQTPLILRIA  218
            R    +A ++ AQA+++S    L  +RI AP+SG +      EG  LNA   T ++  I 
Sbjct  158  R--SAEAGVKAAQAAIKSAGISLNRSRITAPISGFIGQSKVSEGTLLNAGDAT-VLATIR  214

Query  219  KLSPMTVWAQVSEADIGRVK  238
            + +PM V    S +++ +++
Sbjct  215  QTNPMYVNVTQSASEVMKLR  234


>VFG037705(gb|WP_000010636) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii ACICU]
Length=406

 Score = 60.5 bits (145),  Expect = 6e-10, Method: Compositional matrix adjust.
 Identities = 49/178 (28%), Positives = 81/178 (46%), Gaps = 14/178 (8%)

Query  54   GTLQPRRYVDVGAQASGQIRKLHVEAGDDVTEGQLLVEIDPSTQQAKVDAGRYSIEMLKA  113
            G L+    VD+  Q SG++  +H + G  V +G LL  IDP   +A+++         KA
Sbjct  64   GRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAELNRA-------KA  116

Query  114  QLAEQRAQYTLARQQYQRQQRLAAGGATRTEDVQSAQAQMLATQARIEMYQAQIRQAQAS  173
            QLA   AQ T       R QRL    A   +++  A+    +  A ++        A+A+
Sbjct  117  QLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSANANLQA-------ARAA  169

Query  174  LRSDEAELGYTRIYAPMSGTVVAVDAREGQTLNAQQQTPLILRIAKLSPMTVWAQVSE  231
            ++S    L YTRI AP+SG +   +   G  ++A     ++  +  +S +     V E
Sbjct  170  VQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDE  227


>VFG036975(gb|WP_010951249) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria gonorrhoeae FA 1090]
Length=412

 Score = 60.5 bits (145),  Expect = 6e-10, Method: Compositional matrix adjust.
 Identities = 87/345 (25%), Positives = 150/345 (43%), Gaps = 28/345 (8%)

Query  39   VSVSRGSIESSVSALGTLQPRRYVDVGAQASGQIRKLHVEAGDDVTEGQLLVEIDPSTQQ  98
            V+V   ++  +V   G L+  R  DV AQ  G I+K   + G  V  GQ L +ID ST +
Sbjct  50   VTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYE  109

Query  99   AKVDAGRYSIEMLKAQLAEQRAQYTLARQQYQRQQRLAAGGATRTEDVQSAQAQMLATQA  158
            A +++ R       AQLA  +A    A     R + L +  A   ++  +A      T  
Sbjct  110  AGLESAR-------AQLATAQATLAKADADLARYKPLVSADAISKQEYDAA-----VTAK  157

Query  159  RIEMYQAQIRQAQASLRSDEAELGYTRIYAPMSGTVVAVDAREGQTLNAQQQTPLILRIA  218
            R    +A ++ AQA+++S    L  +RI AP+SG +      EG  LNA   T ++  I 
Sbjct  158  R--SAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQSKVSEGTLLNAGDTT-VLATIR  214

Query  219  KLSPMTVWAQVSEADIGRVKPGMPAYFTTLSGEGRRWTGKVRQILPVPPKPLDQSNQGGG  278
            + +PM V    S +++ +++  + A    L+ +G    G       V P   ++      
Sbjct  215  QTNPMYVNVTQSASEVMKLRRQI-AEGKLLAADGAIAVGIKFDDGTVYP---EKGRLLFA  270

Query  279  SPTSGSGGQSGSGRVVLYTVLVDVDNGDHQLMAEMTAQVFFVAATAENILTAPVAAIHDD  338
             PT     +  +G++ L      V N  + LM  +  +V      A+N    P  A+   
Sbjct  271  DPTV----EESTGQITLRAA---VSNDQNILMPGLYVRVLMDQVAADNAFIVPQQAVTRG  323

Query  339  GKGGQVAWVVGSNGKPQSRQIRTGISDRLRVQVLAGLEEGDRLLM  383
             K      +V + G  + R++           V +GL++GD++++
Sbjct  324  AK--DTVMIVNAQGGMEPREVTVAQQQGTNWIVTSGLKDGDKVVV  366


>VFG037706(gb|YP_001085329) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii ATCC 17978]
Length=381

 Score = 60.1 bits (144),  Expect = 7e-10, Method: Compositional matrix adjust.
 Identities = 46/154 (30%), Positives = 73/154 (47%), Gaps = 14/154 (9%)

Query  54   GTLQPRRYVDVGAQASGQIRKLHVEAGDDVTEGQLLVEIDPSTQQAKVDAGRYSIEMLKA  113
            G L+    VD+  Q SG++  +H + G  V +G LL  IDP   +A+++         KA
Sbjct  40   GRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAELNRA-------KA  92

Query  114  QLAEQRAQYTLARQQYQRQQRLAAGGATRTEDVQSAQAQMLATQARIEMYQAQIRQAQAS  173
            QLA   AQ T       R QRL    A   +++  A+    +  A ++        A+A+
Sbjct  93   QLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSANANLQA-------ARAA  145

Query  174  LRSDEAELGYTRIYAPMSGTVVAVDAREGQTLNA  207
            ++S    L YTRI AP+SG +   +   G  ++A
Sbjct  146  VQSARLNLEYTRITAPVSGRISRAEVTVGNVVSA  179


>VFG036981(gb|WP_002232912) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis alpha14]
Length=412

 Score = 60.1 bits (144),  Expect = 8e-10, Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 99/200 (50%), Gaps = 15/200 (8%)

Query  39   VSVSRGSIESSVSALGTLQPRRYVDVGAQASGQIRKLHVEAGDDVTEGQLLVEIDPSTQQ  98
            V+V   ++  +V   G L+  R  DV AQ  G I+K   + G  V  GQ L +ID ST +
Sbjct  50   VTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYE  109

Query  99   AKVDAGRYSIEMLKAQLAEQRAQYTLARQQYQRQQRLAAGGATRTEDVQSAQAQMLATQA  158
            A +++ R  +   +A LA  +A   LAR     +  +AA   +R E   +  A+  A   
Sbjct  110  ANLESARAQLATAQATLA--KADADLAR----YKPLVAAEAVSRQEYDAAVTAKRSA---  160

Query  159  RIEMYQAQIRQAQASLRSDEAELGYTRIYAPMSGTVVAVDAREGQTLNAQQQTPLILRIA  218
                 +A ++ AQA+++S    L  +RI AP+SG +      EG  LNA   T ++  I 
Sbjct  161  -----EAGVKAAQAAIKSAGINLNRSRITAPISGFIGQSKVSEGTLLNAGDTT-VLATIR  214

Query  219  KLSPMTVWAQVSEADIGRVK  238
            + +PM V    S +++ +++
Sbjct  215  QTNPMYVNVTQSASEVMKLR  234


>VFG036984(gb|WP_014580972) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis M01-240149]
Length=412

 Score = 60.1 bits (144),  Expect = 9e-10, Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 99/200 (50%), Gaps = 15/200 (8%)

Query  39   VSVSRGSIESSVSALGTLQPRRYVDVGAQASGQIRKLHVEAGDDVTEGQLLVEIDPSTQQ  98
            V+V   ++  +V   G L+  R  DV AQ  G I+K   + G  V  GQ L +ID ST +
Sbjct  50   VTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYE  109

Query  99   AKVDAGRYSIEMLKAQLAEQRAQYTLARQQYQRQQRLAAGGATRTEDVQSAQAQMLATQA  158
            A +++ R  +   +A LA  +A   LAR     +  +AA   +R E   +  A+  A   
Sbjct  110  ANLESARAQLATAQATLA--KADADLAR----YKPLVAAEAVSRQEYDAAVTAKRSA---  160

Query  159  RIEMYQAQIRQAQASLRSDEAELGYTRIYAPMSGTVVAVDAREGQTLNAQQQTPLILRIA  218
                 +A ++ AQA+++S    L  +RI AP+SG +      EG  LNA   T ++  I 
Sbjct  161  -----EAGVKAAQAAIKSAGINLNRSRITAPISGFIGQSKVSEGTLLNAGDTT-VLATIR  214

Query  219  KLSPMTVWAQVSEADIGRVK  238
            + +PM V    S +++ +++
Sbjct  215  QTNPMYVNVTQSASEVMKLR  234


>VFG036979(gb|WP_002246382) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis WUE 2594]
Length=412

 Score = 60.1 bits (144),  Expect = 9e-10, Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 99/200 (50%), Gaps = 15/200 (8%)

Query  39   VSVSRGSIESSVSALGTLQPRRYVDVGAQASGQIRKLHVEAGDDVTEGQLLVEIDPSTQQ  98
            V+V   ++  +V   G L+  R  DV AQ  G I+K   + G  V  GQ L +ID ST +
Sbjct  50   VTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYE  109

Query  99   AKVDAGRYSIEMLKAQLAEQRAQYTLARQQYQRQQRLAAGGATRTEDVQSAQAQMLATQA  158
            A +++ R  +   +A LA  +A   LAR     +  +AA   +R E   +  A+  A   
Sbjct  110  ANLESARAQLATAQATLA--KADADLAR----YKPLVAAEAVSRQEYDAAVTAKRSA---  160

Query  159  RIEMYQAQIRQAQASLRSDEAELGYTRIYAPMSGTVVAVDAREGQTLNAQQQTPLILRIA  218
                 +A ++ AQA+++S    L  +RI AP+SG +      EG  LNA   T ++  I 
Sbjct  161  -----EAGVKAAQAAIKSAGINLNRSRITAPISGFIGQSKVSEGTLLNAGDTT-VLATIR  214

Query  219  KLSPMTVWAQVSEADIGRVK  238
            + +PM V    S +++ +++
Sbjct  215  QTNPMYVNVTQSASEVMKLR  234


>VFG036983(gb|WP_002216627) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis G2136]
Length=412

 Score = 59.7 bits (143),  Expect = 9e-10, Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 99/200 (50%), Gaps = 15/200 (8%)

Query  39   VSVSRGSIESSVSALGTLQPRRYVDVGAQASGQIRKLHVEAGDDVTEGQLLVEIDPSTQQ  98
            V+V   ++  +V   G L+  R  DV AQ  G I+K   + G  V  GQ L +ID ST +
Sbjct  50   VTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYE  109

Query  99   AKVDAGRYSIEMLKAQLAEQRAQYTLARQQYQRQQRLAAGGATRTEDVQSAQAQMLATQA  158
            A +++ R  +   +A LA  +A   LAR     +  +AA   +R E   +  A+  A   
Sbjct  110  ANLESARAQLATAQATLA--KADADLAR----YKPLVAAEAVSRQEYDAAVTAKRSA---  160

Query  159  RIEMYQAQIRQAQASLRSDEAELGYTRIYAPMSGTVVAVDAREGQTLNAQQQTPLILRIA  218
                 +A ++ AQA+++S    L  +RI AP+SG +      EG  LNA   T ++  I 
Sbjct  161  -----EAGVKAAQAAIKSAGINLNRSRITAPISGFIGQSKVSEGTLLNAGDTT-VLATIR  214

Query  219  KLSPMTVWAQVSEADIGRVK  238
            + +PM V    S +++ +++
Sbjct  215  QTNPMYVNVTQSASEVMKLR  234


>VFG036980(gb|WP_014573842) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis 8013]
Length=412

 Score = 59.7 bits (143),  Expect = 9e-10, Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 99/200 (50%), Gaps = 15/200 (8%)

Query  39   VSVSRGSIESSVSALGTLQPRRYVDVGAQASGQIRKLHVEAGDDVTEGQLLVEIDPSTQQ  98
            V+V   ++  +V   G L+  R  DV AQ  G I+K   + G  V  GQ L +ID ST +
Sbjct  50   VTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYE  109

Query  99   AKVDAGRYSIEMLKAQLAEQRAQYTLARQQYQRQQRLAAGGATRTEDVQSAQAQMLATQA  158
            A +++ R  +   +A LA  +A   LAR     +  +AA   +R E   +  A+  A   
Sbjct  110  ANLESARAQLATAQATLA--KADADLAR----YKPLVAAEAVSRQEYDAAVTAKRSA---  160

Query  159  RIEMYQAQIRQAQASLRSDEAELGYTRIYAPMSGTVVAVDAREGQTLNAQQQTPLILRIA  218
                 +A ++ AQA+++S    L  +RI AP+SG +      EG  LNA   T ++  I 
Sbjct  161  -----EAGVKAAQAAIKSAGINLNRSRITAPISGFIGQSKVSEGTLLNAGDTT-VLATIR  214

Query  219  KLSPMTVWAQVSEADIGRVK  238
            + +PM V    S +++ +++
Sbjct  215  QTNPMYVNVTQSASEVMKLR  234


>VFG036982(gb|WP_002224350) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis alpha710]
Length=412

 Score = 59.7 bits (143),  Expect = 9e-10, Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 99/200 (50%), Gaps = 15/200 (8%)

Query  39   VSVSRGSIESSVSALGTLQPRRYVDVGAQASGQIRKLHVEAGDDVTEGQLLVEIDPSTQQ  98
            V+V   ++  +V   G L+  R  DV AQ  G I+K   + G  V  GQ L +ID ST +
Sbjct  50   VTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYE  109

Query  99   AKVDAGRYSIEMLKAQLAEQRAQYTLARQQYQRQQRLAAGGATRTEDVQSAQAQMLATQA  158
            A +++ R  +   +A LA  +A   LAR     +  +AA   +R E   +  A+  A   
Sbjct  110  ANLESARAQLATAQATLA--KADADLAR----YKPLVAAEAVSRQEYDAAVTAKRSA---  160

Query  159  RIEMYQAQIRQAQASLRSDEAELGYTRIYAPMSGTVVAVDAREGQTLNAQQQTPLILRIA  218
                 +A ++ AQA+++S    L  +RI AP+SG +      EG  LNA   T ++  I 
Sbjct  161  -----EAGVKAAQAAIKSAGINLNRSRITAPISGFIGQSKVSEGTLLNAGDTT-VLATIR  214

Query  219  KLSPMTVWAQVSEADIGRVK  238
            + +PM V    S +++ +++
Sbjct  215  QTNPMYVNVTQSASEVMKLR  234


>VFG036978(gb|WP_004465401) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria gonorrhoeae NCCP11945]
Length=412

 Score = 59.7 bits (143),  Expect = 1e-09, Method: Compositional matrix adjust.
 Identities = 87/345 (25%), Positives = 149/345 (43%), Gaps = 28/345 (8%)

Query  39   VSVSRGSIESSVSALGTLQPRRYVDVGAQASGQIRKLHVEAGDDVTEGQLLVEIDPSTQQ  98
            V+V   ++  +V   G L+  R  DV AQ  G I+K   + G  V  GQ L +ID ST +
Sbjct  50   VTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYE  109

Query  99   AKVDAGRYSIEMLKAQLAEQRAQYTLARQQYQRQQRLAAGGATRTEDVQSAQAQMLATQA  158
            A +++ R       AQLA  +A    A     R + L +  A   ++  +A      T  
Sbjct  110  AGLESAR-------AQLATAQATLAKADADLARYKPLVSADAISKQEYDAA-----VTAK  157

Query  159  RIEMYQAQIRQAQASLRSDEAELGYTRIYAPMSGTVVAVDAREGQTLNAQQQTPLILRIA  218
            R    +A ++ AQA+++S    L  +RI AP+SG +      EG  LNA   T ++  I 
Sbjct  158  R--SAEAGVKAAQAAIKSAGINLNRSRITAPISGFIGQSKVSEGTLLNAGDTT-VLATIR  214

Query  219  KLSPMTVWAQVSEADIGRVKPGMPAYFTTLSGEGRRWTGKVRQILPVPPKPLDQSNQGGG  278
            + +PM V    S +++ +++  + A    L+ +G    G       V P   ++      
Sbjct  215  QTNPMYVNVTQSASEVMKLRRQI-AEGKLLAADGAIAVGIKFDDGTVYP---EKGRLLFA  270

Query  279  SPTSGSGGQSGSGRVVLYTVLVDVDNGDHQLMAEMTAQVFFVAATAENILTAPVAAIHDD  338
             PT        +G++ L      V N  + LM  +  +V      A+N    P  A+   
Sbjct  271  DPTV----DESTGQITLRAA---VSNDQNILMPGLYVRVLMDQVAADNAFIVPQQAVTRG  323

Query  339  GKGGQVAWVVGSNGKPQSRQIRTGISDRLRVQVLAGLEEGDRLLM  383
             K      +V + G  + R++           V +GL++GD++++
Sbjct  324  AK--DTVMIVNAQGGMEPREVTVAQQQGTNWIVTSGLKDGDKVVV  366


>VFG036976(gb|WP_002220426) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis FAM18]
Length=412

 Score = 59.3 bits (142),  Expect = 1e-09, Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 99/200 (50%), Gaps = 15/200 (8%)

Query  39   VSVSRGSIESSVSALGTLQPRRYVDVGAQASGQIRKLHVEAGDDVTEGQLLVEIDPSTQQ  98
            V+V   ++  +V   G L+  R  DV AQ  G I+K   + G  V  GQ L +ID ST +
Sbjct  50   VTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYE  109

Query  99   AKVDAGRYSIEMLKAQLAEQRAQYTLARQQYQRQQRLAAGGATRTEDVQSAQAQMLATQA  158
            A +++ R  +   +A LA  +A   LAR     +  +AA   +R E   +  A+  A   
Sbjct  110  AGLESARAQLATAQATLA--KADADLAR----YKPLVAAEAVSRQEYDAAVTAKRSA---  160

Query  159  RIEMYQAQIRQAQASLRSDEAELGYTRIYAPMSGTVVAVDAREGQTLNAQQQTPLILRIA  218
                 +A ++ AQA+++S    L  +RI AP+SG +      EG  LNA   T ++  I 
Sbjct  161  -----EAGVKAAQAAIKSAGINLNRSRITAPISGFIGQSKVSEGTLLNAGDTT-VLATIR  214

Query  219  KLSPMTVWAQVSEADIGRVK  238
            + +PM V    S +++ +++
Sbjct  215  QTNPMYVNVTQSASEVMKLR  234


>VFG036973(gb|WP_002222106) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis Z2491]
Length=412

 Score = 58.9 bits (141),  Expect = 2e-09, Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 99/200 (50%), Gaps = 15/200 (8%)

Query  39   VSVSRGSIESSVSALGTLQPRRYVDVGAQASGQIRKLHVEAGDDVTEGQLLVEIDPSTQQ  98
            V+V   ++  +V   G L+  R  DV AQ  G I+K   + G  V  GQ L +ID ST +
Sbjct  50   VTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYE  109

Query  99   AKVDAGRYSIEMLKAQLAEQRAQYTLARQQYQRQQRLAAGGATRTEDVQSAQAQMLATQA  158
            A +++ R  +   +A LA  +A   LAR     +  +AA   +R E   +  A+  A   
Sbjct  110  AGLESARAQLATAQATLA--KADADLAR----YKPLVAAEAVSRQEYDAAVTAKRSA---  160

Query  159  RIEMYQAQIRQAQASLRSDEAELGYTRIYAPMSGTVVAVDAREGQTLNAQQQTPLILRIA  218
                 +A ++ AQA+++S    L  +RI AP+SG +      EG  LNA   T ++  I 
Sbjct  161  -----EAGVKAAQAAIKSAGINLNRSRITAPISGFIGQSKVSEGTLLNAGDTT-VLATIR  214

Query  219  KLSPMTVWAQVSEADIGRVK  238
            + +PM V    S +++ +++
Sbjct  215  QTNPMYVNVTQSASEVMKLR  234


>VFG036990(gb|WP_013448559) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria lactamica 020-06]
Length=412

 Score = 58.9 bits (141),  Expect = 2e-09, Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 99/200 (50%), Gaps = 15/200 (8%)

Query  39   VSVSRGSIESSVSALGTLQPRRYVDVGAQASGQIRKLHVEAGDDVTEGQLLVEIDPSTQQ  98
            V+V   ++  +V   G L+  R  DV AQ  G I+K   + G  V  GQ L +ID ST +
Sbjct  50   VTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYE  109

Query  99   AKVDAGRYSIEMLKAQLAEQRAQYTLARQQYQRQQRLAAGGATRTEDVQSAQAQMLATQA  158
            A +++ R  +   +A LA  +A   LAR     +  +AA   +R E   +  A+  A   
Sbjct  110  AGLESARAQLATAQATLA--KADADLAR----YKPLVAAEAVSRQEYDAAVTAKRSA---  160

Query  159  RIEMYQAQIRQAQASLRSDEAELGYTRIYAPMSGTVVAVDAREGQTLNAQQQTPLILRIA  218
                 +A ++ AQA+++S    L  +RI AP+SG +      EG  LNA   T ++  I 
Sbjct  161  -----EAGVKAAQAAIKSAGINLNRSRITAPISGFIGQSKVSEGTLLNAGDTT-VLATIR  214

Query  219  KLSPMTVWAQVSEADIGRVK  238
            + +PM V    S +++ +++
Sbjct  215  QTNPMYVNVTQSASEVMKLR  234


>VFG036974(gb|WP_002224968) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis MC58]
Length=412

 Score = 58.9 bits (141),  Expect = 2e-09, Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 99/200 (50%), Gaps = 15/200 (8%)

Query  39   VSVSRGSIESSVSALGTLQPRRYVDVGAQASGQIRKLHVEAGDDVTEGQLLVEIDPSTQQ  98
            V+V   ++  +V   G L+  R  DV AQ  G I+K   + G  V  GQ L +ID ST +
Sbjct  50   VTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYE  109

Query  99   AKVDAGRYSIEMLKAQLAEQRAQYTLARQQYQRQQRLAAGGATRTEDVQSAQAQMLATQA  158
            A +++ R  +   +A LA  +A   LAR     +  +AA   +R E   +  A+  A   
Sbjct  110  AGLESARAQLATAQATLA--KADADLAR----YKPLVAAEAVSRQEYDAAVTAKRSA---  160

Query  159  RIEMYQAQIRQAQASLRSDEAELGYTRIYAPMSGTVVAVDAREGQTLNAQQQTPLILRIA  218
                 +A ++ AQA+++S    L  +RI AP+SG +      EG  LNA   T ++  I 
Sbjct  161  -----EAGVKAAQAAIKSAGISLNRSRITAPISGFIGQSKVSEGTLLNAGDAT-VLATIR  214

Query  219  KLSPMTVWAQVSEADIGRVK  238
            + +PM V    S +++ +++
Sbjct  215  QTNPMYVNVTQSASEVMKLR  234


>VFG049129(gb|YP_005225489) (acrA) acriflavine resistance protein 
A [AcrAB (VF0568) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Klebsiella pneumoniae subsp. pneumoniae 
HS11286]
Length=397

 Score = 57.8 bits (138),  Expect = 4e-09, Method: Compositional matrix adjust.
 Identities = 93/384 (24%), Positives = 151/384 (39%), Gaps = 43/384 (11%)

Query  11   LLVAVCLSPLIALAAWQAYPFRSN-----NFDTVSVSRGSIESSVSALGTLQPRRYVDVG  65
            L V + LS  +AL      P +           V++    ++ +    G     R  +V 
Sbjct  10   LAVVLMLSGSLALTGCDDKPAQQGAQHMPEVGIVTLKSAPLQITTELPGRTSAYRIAEVR  69

Query  66   AQASGQIRKLHVEAGDDVTEGQLLVEIDPSTQQAKVDAGRYSIEMLKAQLAEQRAQYTLA  125
             Q SG I K +   G D+  G  L +IDP+T QA  D+ +   ++ KAQ A    Q T+ 
Sbjct  70   PQVSGIILKRNFVEGSDIQAGVSLYQIDPATYQASYDSAKG--DLAKAQAAANMDQLTV-  126

Query  126  RQQYQRQQRLAAGGATRTEDVQSAQAQMLATQARIEMYQAQIRQAQASLRSDEAELGYTR  185
                +R Q+L        +D  +A A   A Q+   +  A+     A +      L YT+
Sbjct  127  ----KRYQKLLGTKYISQQDYDTAVA--TAQQSNAAVVAAKAAVETARIN-----LAYTK  175

Query  186  IYAPMSGTVVAVDAREGQTLNAQQQTPLILRIAKLSPMTVWAQVSEADIGRVKPGMPAYF  245
            + +P+SG +      EG  +   Q T L   + +L P+ V    S  D  R+K  +    
Sbjct  176  VTSPISGRIGKSTVTEGALVQNGQTTALA-TVQQLDPIYVDVTQSSNDFLRLKQELA---  231

Query  246  TTLSGEGRRWTGKVRQILPVPPKPLDQSNQGGGSPTSGSGGQSG------SGRVVLYTVL  299
                G  ++  GK +  L         +N G   P SG+   S       +G + L  + 
Sbjct  232  ---DGRLKQENGKAKVELV--------TNDGLKYPQSGTLEFSDVTVDQTTGSITLRAIF  280

Query  300  VDVDNGDHQLMAEMTAQVFFVAATAENILTAPVAAIHDDGKGGQVAWVVGSNGKPQSRQI  359
                N DH L+  M  +         + L  P   +    +G     VVG   K + RQ+
Sbjct  281  ---PNPDHTLLPGMFVRARLEEGINPDALLVPQQGVTRTPRGDASVMVVGEGDKVEVRQV  337

Query  360  RTGISDRLRVQVLAGLEEGDRLLM  383
                +   +  V  GL+ GDR+++
Sbjct  338  TASQAIGDKWLVTDGLKSGDRVIV  361


>VFG049125(gb|WP_004136054) (acrA) acriflavine resistance protein 
A [AcrAB (VF0568) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Klebsiella oxytoca E718]
Length=397

 Score = 57.8 bits (138),  Expect = 5e-09, Method: Compositional matrix adjust.
 Identities = 95/386 (25%), Positives = 155/386 (40%), Gaps = 47/386 (12%)

Query  11   LLVAVCLSPLIALAAWQAYPFRSN-----NFDTVSVSRGSIESSVSALGTLQPRRYVDVG  65
            L V + LS  +AL      P +           V++    ++ +    G     R  +V 
Sbjct  10   LAVVLMLSGSLALTGCDDKPAQQGAQQMPEVGIVTLKSAPLQITTELPGRTSAYRVAEVR  69

Query  66   AQASGQIRKLHVEAGDDVTEGQLLVEIDPSTQQAKVDAGRYSIEMLKAQLAEQRAQYTLA  125
             Q SG I K +   G D+  G  L +IDP+T QA  ++ +   ++ KAQ A    Q T+ 
Sbjct  70   PQVSGIILKRNFTEGSDIQAGVSLYQIDPATYQATYESAKG--DLAKAQAAANMDQLTV-  126

Query  126  RQQYQRQQRLAAGGATRTEDVQSAQAQMLATQARIEMYQAQIRQAQASLRSDEAELGYTR  185
                +R Q+L        +D  +A A   A Q+   +  A+     A +      L YT+
Sbjct  127  ----KRYQKLLGTKYISQQDYDTAVA--TAQQSNAAVVAAKAAVETARIN-----LAYTK  175

Query  186  IYAPMSGTVVAVDAREGQTLNAQQQTPLILRIAKLSPMTVWAQVSEADIGRVKPGMPAYF  245
            + +P+SG +      EG  L    QT  +  + +L P+ V    S  D  R+K  +    
Sbjct  176  VTSPISGRIGKSAVTEG-ALVQNGQTTALATVQQLDPIYVDVTQSSNDFLRLKQELA---  231

Query  246  TTLSGEGRRWTGKVRQILPVPPKPLDQSNQGGGSPTSGSGGQSG------SGRVVLYTVL  299
               +G+ ++  GK +  L         +N G   P +G+   S       +G + L  + 
Sbjct  232  ---NGKLQQENGKAKVELV--------TNDGLKYPQNGTLEFSDVTVDQTTGSITLRAIF  280

Query  300  VDVDNGDHQLMAEMTAQVFFVAATAENILTAPVAAIHDDGKGGQVAWVVGSNGKPQSRQI  359
                N DH L+  M  +         + L  P   +    +G   A VVG   K + RQI
Sbjct  281  ---PNPDHTLLPGMFVRARLEEGVNPDALLVPQQGVTRTPRGDASAMVVGEGDKVEVRQI  337

Query  360  RT--GISDRLRVQVLAGLEEGDRLLM  383
                 I D+    V  GL+ GDR+++
Sbjct  338  TATQAIGDKWL--VTEGLKTGDRVII  361


>VFG049133(gb|WP_004177236) (acrA) acriflavine resistance protein 
A [AcrAB (VF0568) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Klebsiella pneumoniae subsp. pneumoniae 
NTUH-K2044]
Length=397

 Score = 57.4 bits (137),  Expect = 5e-09, Method: Compositional matrix adjust.
 Identities = 93/384 (24%), Positives = 151/384 (39%), Gaps = 43/384 (11%)

Query  11   LLVAVCLSPLIALAAWQAYPFRSN-----NFDTVSVSRGSIESSVSALGTLQPRRYVDVG  65
            L V + LS  +AL      P +           V++    ++ +    G     R  +V 
Sbjct  10   LAVVLMLSGSLALTGCDDKPAQQGAQHMPEVGIVTLKSAPLQITTELPGRTSAYRIAEVR  69

Query  66   AQASGQIRKLHVEAGDDVTEGQLLVEIDPSTQQAKVDAGRYSIEMLKAQLAEQRAQYTLA  125
             Q SG I K +   G D+  G  L +IDP+T QA  D+ +   ++ KAQ A    Q T+ 
Sbjct  70   PQVSGIILKRNFVEGSDIQAGVSLYQIDPATYQASYDSAKG--DLAKAQAAANMDQLTV-  126

Query  126  RQQYQRQQRLAAGGATRTEDVQSAQAQMLATQARIEMYQAQIRQAQASLRSDEAELGYTR  185
                +R Q+L        +D  +A A   A Q+   +  A+     A +      L YT+
Sbjct  127  ----KRYQKLLGTKYISQQDYDTAVA--TAQQSNAAVVAAKAAVETARIN-----LAYTK  175

Query  186  IYAPMSGTVVAVDAREGQTLNAQQQTPLILRIAKLSPMTVWAQVSEADIGRVKPGMPAYF  245
            + +P+SG +      EG  +   Q T L   + +L P+ V    S  D  R+K  +    
Sbjct  176  VTSPISGRIGKSAVTEGALVQNGQTTALA-TVQQLDPIYVDVTQSSNDFLRLKQELA---  231

Query  246  TTLSGEGRRWTGKVRQILPVPPKPLDQSNQGGGSPTSGSGGQSG------SGRVVLYTVL  299
                G  ++  GK +  L         +N G   P SG+   S       +G + L  + 
Sbjct  232  ---DGRLKQENGKAKVELV--------TNDGLKYPQSGTLEFSDVTVDQTTGSITLRAIF  280

Query  300  VDVDNGDHQLMAEMTAQVFFVAATAENILTAPVAAIHDDGKGGQVAWVVGSNGKPQSRQI  359
                N DH L+  M  +         + L  P   +    +G     VVG   K + RQ+
Sbjct  281  ---PNPDHTLLPGMFVRARLEEGINPDALLVPQQGVTRTPRGDASVMVVGEGDKVEVRQV  337

Query  360  RTGISDRLRVQVLAGLEEGDRLLM  383
                +   +  V  GL+ GDR+++
Sbjct  338  TASQAIGDKWLVTDGLKSGDRVIV  361


>VFG049135(gb|WP_008805438) (acrA) acriflavine resistance protein 
A [AcrAB (VF0568) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Klebsiella variicola At-22]
Length=397

 Score = 56.2 bits (134),  Expect = 1e-08, Method: Compositional matrix adjust.
 Identities = 92/384 (24%), Positives = 151/384 (39%), Gaps = 43/384 (11%)

Query  11   LLVAVCLSPLIALAAWQAYPFRSN-----NFDTVSVSRGSIESSVSALGTLQPRRYVDVG  65
            L V + LS  +AL      P +           V++    ++ +    G     R  +V 
Sbjct  10   LAVVLMLSGSLALTGCDDKPAQQGAQHMPEVGIVTLKSAPLQITTELPGRTSAYRIAEVR  69

Query  66   AQASGQIRKLHVEAGDDVTEGQLLVEIDPSTQQAKVDAGRYSIEMLKAQLAEQRAQYTLA  125
             Q SG I K +   G D+  G  L +IDP+T QA  D+ +   ++ KAQ A    Q T+ 
Sbjct  70   PQVSGIILKRNFVEGSDIQAGVSLYQIDPATYQASYDSAKG--DLAKAQAAANMDQLTV-  126

Query  126  RQQYQRQQRLAAGGATRTEDVQSAQAQMLATQARIEMYQAQIRQAQASLRSDEAELGYTR  185
                +R Q+L        +D  +A A   A Q+   +  A+     A +      L YT+
Sbjct  127  ----KRYQKLLGTKYISQQDYDTAVA--TAQQSNAAVVAAKAAVETARIN-----LAYTK  175

Query  186  IYAPMSGTVVAVDAREGQTLNAQQQTPLILRIAKLSPMTVWAQVSEADIGRVKPGMPAYF  245
            + +P+SG +      EG  L    QT  +  + +L P+ V    S  D  R+K  +    
Sbjct  176  VTSPISGRIGKSAVTEG-ALVQNGQTTALATVQQLDPIYVDVTQSSNDFLRLKQELA---  231

Query  246  TTLSGEGRRWTGKVRQILPVPPKPLDQSNQGGGSPTSGSGGQSG------SGRVVLYTVL  299
                G  ++  GK +  L         +N G   P +G+   S       +G + L  + 
Sbjct  232  ---DGRLKQENGKAKVELV--------TNDGLKYPQAGTLEFSDVTVDQTTGSITLRAIF  280

Query  300  VDVDNGDHQLMAEMTAQVFFVAATAENILTAPVAAIHDDGKGGQVAWVVGSNGKPQSRQI  359
                N DH L+  M  +         + L  P   +    +G     VVG   K + RQ+
Sbjct  281  ---PNPDHTLLPGMFVRARLEEGVNPDALLVPQQGVTRTPRGDASVMVVGEGDKVEVRQV  337

Query  360  RTGISDRLRVQVLAGLEEGDRLLM  383
                +   +  V  GL+ GDR+++
Sbjct  338  TASQAIGDKWLVTDGLKTGDRVIV  361


>VFG049128(gb|WP_012542667) (acrA) acriflavine resistance protein 
A [AcrAB (VF0568) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Klebsiella pneumoniae 342]
Length=397

 Score = 56.2 bits (134),  Expect = 1e-08, Method: Compositional matrix adjust.
 Identities = 92/384 (24%), Positives = 151/384 (39%), Gaps = 43/384 (11%)

Query  11   LLVAVCLSPLIALAAWQAYPFRSN-----NFDTVSVSRGSIESSVSALGTLQPRRYVDVG  65
            L V + LS  +AL      P +           V++    ++ +    G     R  +V 
Sbjct  10   LAVVLMLSGSLALTGCDDKPAQQGAQHMPEVGIVTLKSAPLQITTELPGRTSAYRIAEVR  69

Query  66   AQASGQIRKLHVEAGDDVTEGQLLVEIDPSTQQAKVDAGRYSIEMLKAQLAEQRAQYTLA  125
             Q SG I K +   G D+  G  L +IDP+T QA  D+ +   ++ KAQ A    Q T+ 
Sbjct  70   PQVSGIILKRNFVEGSDIQAGVSLYQIDPATYQASYDSAKG--DLAKAQAAANMDQLTV-  126

Query  126  RQQYQRQQRLAAGGATRTEDVQSAQAQMLATQARIEMYQAQIRQAQASLRSDEAELGYTR  185
                +R Q+L        +D  +A A   A Q+   +  A+     A +      L YT+
Sbjct  127  ----KRYQKLLGTKYISQQDYDTAVA--TAQQSNAAVVAAKAAVETARIN-----LAYTK  175

Query  186  IYAPMSGTVVAVDAREGQTLNAQQQTPLILRIAKLSPMTVWAQVSEADIGRVKPGMPAYF  245
            + +P+SG +      EG  L    QT  +  + +L P+ V    S  D  R+K  +    
Sbjct  176  VTSPISGRIGKSAVTEG-ALVQNGQTTALATVQQLDPIYVDVTQSSNDFLRLKQELA---  231

Query  246  TTLSGEGRRWTGKVRQILPVPPKPLDQSNQGGGSPTSGSGGQSG------SGRVVLYTVL  299
                G  ++  GK +  L         +N G   P +G+   S       +G + L  + 
Sbjct  232  ---DGRLKQENGKAKVELV--------TNDGLKYPQAGTLEFSDVTVDQTTGSITLRAIF  280

Query  300  VDVDNGDHQLMAEMTAQVFFVAATAENILTAPVAAIHDDGKGGQVAWVVGSNGKPQSRQI  359
                N DH L+  M  +         + L  P   +    +G     VVG   K + RQ+
Sbjct  281  ---PNPDHTLLPGMFVRARLEEGVNPDALLVPQQGVTRTPRGDASVMVVGEGDKVEVRQV  337

Query  360  RTGISDRLRVQVLAGLEEGDRLLM  383
                +   +  V  GL+ GDR+++
Sbjct  338  TASQAIGDKWLVTDGLKTGDRVIV  361



Lambda      K        H        a         alpha
   0.315    0.129    0.361    0.792     4.96 

Gapped
Lambda      K        H        a         alpha    sigma
   0.267   0.0410    0.140     1.90     42.6     43.6 

Effective search space used: 3018379291


Query= g879.t1

Length=372
                                                                      Score     E
Sequences producing significant alignments:                          (Bits)  Value

VFG037711(gb|WP_000010646) (adeF) membrane-fusion protein [AdeFGH...  99.4    4e-23
VFG037714(gb|WP_000010641) (adeF) membrane-fusion protein [AdeFGH...  99.4    4e-23
VFG037709(gb|WP_000010642) (adeF) membrane-fusion protein [AdeFGH...  99.4    5e-23
VFG037705(gb|WP_000010636) (adeF) membrane-fusion protein [AdeFGH...  99.4    5e-23
VFG037706(gb|YP_001085329) (adeF) membrane-fusion protein [AdeFGH...  99.0    6e-23
VFG036982(gb|WP_002224350) (mtrC) membrane fusion protein MtrC [M...  89.0    2e-19
VFG036980(gb|WP_014573842) (mtrC) membrane fusion protein MtrC [M...  89.0    2e-19
VFG036984(gb|WP_014580972) (mtrC) membrane fusion protein MtrC [M...  88.6    3e-19
VFG036973(gb|WP_002222106) (mtrC) membrane fusion protein MtrC [M...  88.6    3e-19
VFG036981(gb|WP_002232912) (mtrC) membrane fusion protein MtrC [M...  88.2    3e-19
VFG036976(gb|WP_002220426) (mtrC) membrane fusion protein MtrC [M...  88.2    3e-19
VFG036979(gb|WP_002246382) (mtrC) membrane fusion protein MtrC [M...  88.2    3e-19
VFG036983(gb|WP_002216627) (mtrC) membrane fusion protein MtrC [M...  88.2    4e-19
VFG036987(gb|WP_014582209) (mtrC) membrane fusion protein MtrC [M...  87.8    5e-19
VFG036974(gb|WP_002224968) (mtrC) membrane fusion protein MtrC [M...  87.4    6e-19
VFG036990(gb|WP_013448559) (mtrC) membrane fusion protein MtrC [M...  85.9    2e-18
VFG036975(gb|WP_010951249) (mtrC) membrane fusion protein MtrC [M...  83.6    1e-17
VFG036978(gb|WP_004465401) (mtrC) membrane fusion protein MtrC [M...  82.4    3e-17
VFG049129(gb|YP_005225489) (acrA) acriflavine resistance protein ...  55.1    3e-08
VFG049125(gb|WP_004136054) (acrA) acriflavine resistance protein ...  53.9    6e-08
VFG049133(gb|WP_004177236) (acrA) acriflavine resistance protein ...  53.1    1e-07
VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protei...  52.4    2e-07
VFG049128(gb|WP_012542667) (acrA) acriflavine resistance protein ...  52.0    2e-07
VFG049135(gb|WP_008805438) (acrA) acriflavine resistance protein ...  52.0    3e-07
VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protei...  50.4    8e-07
VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protei...  49.3    2e-06
VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protei...  48.1    4e-06
VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protei...  48.1    5e-06
VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protei...  47.8    6e-06
VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protei...  47.8    6e-06
VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protei...  47.8    6e-06
VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protei...  47.8    7e-06


>VFG037711(gb|WP_000010646) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii D1279779]
Length=405

 Score = 99.4 bits (246),  Expect = 4e-23, Method: Compositional matrix adjust.
 Identities = 91/325 (28%), Positives = 154/325 (47%), Gaps = 26/325 (8%)

Query  54   TGKLDALRKVDVGAQVSGQLKTLLVSIGDNVKKDQLLGVIDPDQAENQIKEVEATLMELN  113
            +G+L+A+ +VD+  QVSG+L  +    G  VKK  LL  IDP       +  EA L    
Sbjct  63   SGRLEAIDQVDIRPQVSGKLVAVHFKDGSLVKKGDLLFTIDP-------RPFEAELNRAK  115

Query  114  AERQQAAAELKLARVTLARQQQLAKTQAVSQQDLDTAATEMAVKQARIGTIDAQIKRNRA  173
            A+   A A++      L+R Q+L ++ AVS+Q+LD     +A   AR  + +A ++  RA
Sbjct  116  AQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELD-----LAENDAR--SANANLQAARA  168

Query  174  SLDTAKTNLEYTRIVAPMAGEVTQITTLQGQTVIAAQQAPNILTLADMSTMLVKAQVSEA  233
            ++ +A+ NLEYTRI AP++G +++     G  V A   A  + +L  +S +     V E 
Sbjct  169  AVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDEQ  228

Query  234  DVIHLRAGQK------AWFTIAGDPQTRYEGVLKDILPTPEKINDAIFYYARFEVPNPKR  287
              +   + Q+       +  +A +     EG +  I       +  I   A F+  NP  
Sbjct  229  TYLKYISNQRNSSQVPVYMGLANETGFTREGTINSIDNNLNTTSGTIRVRATFD--NPNG  286

Query  288  ILRLDMTAQVYIQLMDVKNVLIIPLAALGEPVGGNRYKVALLRNGEKREREVVIGERNDT  347
            +L   + A++ +     +  ++I   A+G      R+ V +    +   REV +G + D 
Sbjct  287  VLLPGLYARIRLGGGQPRPAILISPTAVGVD-QDKRFVVVVDAKNQTAYREVKLGAQQDG  345

Query  348  DVEVVKGLEAGDEVIIG---ESRPG  369
               V  GL+AGD +++      RPG
Sbjct  346  LQIVNSGLQAGDRIVVNGLQRIRPG  370


>VFG037714(gb|WP_000010641) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii SDF]
Length=405

 Score = 99.4 bits (246),  Expect = 4e-23, Method: Compositional matrix adjust.
 Identities = 91/325 (28%), Positives = 154/325 (47%), Gaps = 26/325 (8%)

Query  54   TGKLDALRKVDVGAQVSGQLKTLLVSIGDNVKKDQLLGVIDPDQAENQIKEVEATLMELN  113
            +G+L+A+ +VD+  QVSG+L  +    G  VKK  LL  IDP       +  EA L    
Sbjct  63   SGRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDP-------RPFEAELNRAK  115

Query  114  AERQQAAAELKLARVTLARQQQLAKTQAVSQQDLDTAATEMAVKQARIGTIDAQIKRNRA  173
            A+   A A++      L+R Q+L ++ AVS+Q+LD     +A   AR  + +A ++  RA
Sbjct  116  AQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELD-----LAENDAR--SANANLQAARA  168

Query  174  SLDTAKTNLEYTRIVAPMAGEVTQITTLQGQTVIAAQQAPNILTLADMSTMLVKAQVSEA  233
            ++ +A+ NLEYTRI AP++G +++     G  V A   A  + +L  +S +     V E 
Sbjct  169  AVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDEQ  228

Query  234  DVIHLRAGQK------AWFTIAGDPQTRYEGVLKDILPTPEKINDAIFYYARFEVPNPKR  287
              +   + Q+       +  +A +     EG +  I       +  I   A F+  NP  
Sbjct  229  TYLKYISNQRNSSQVPVYMGLANETGFTREGTINSIDNNLNTTSGTIRVRATFD--NPNG  286

Query  288  ILRLDMTAQVYIQLMDVKNVLIIPLAALGEPVGGNRYKVALLRNGEKREREVVIGERNDT  347
            +L   + A++ +     +  ++I   A+G      R+ V +    +   REV +G + D 
Sbjct  287  VLLPGLYARIRLGGGQPRPAILISPTAVGVD-QDKRFVVVVDAKNQTAYREVKLGAQQDG  345

Query  348  DVEVVKGLEAGDEVIIG---ESRPG  369
               V  GL+AGD +++      RPG
Sbjct  346  LQIVNSGLQAGDRIVVNGLQRIRPG  370


>VFG037709(gb|WP_000010642) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii BJAB0715]
Length=406

 Score = 99.4 bits (246),  Expect = 5e-23, Method: Compositional matrix adjust.
 Identities = 91/325 (28%), Positives = 154/325 (47%), Gaps = 26/325 (8%)

Query  54   TGKLDALRKVDVGAQVSGQLKTLLVSIGDNVKKDQLLGVIDPDQAENQIKEVEATLMELN  113
            +G+L+A+ +VD+  QVSG+L  +    G  VKK  LL  IDP       +  EA L    
Sbjct  63   SGRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDP-------RPFEAELNRAK  115

Query  114  AERQQAAAELKLARVTLARQQQLAKTQAVSQQDLDTAATEMAVKQARIGTIDAQIKRNRA  173
            A+   A A++      L+R Q+L ++ AVS+Q+LD     +A   AR  + +A ++  RA
Sbjct  116  AQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELD-----LAENDAR--SANANLQAARA  168

Query  174  SLDTAKTNLEYTRIVAPMAGEVTQITTLQGQTVIAAQQAPNILTLADMSTMLVKAQVSEA  233
            ++ +A+ NLEYTRI AP++G +++     G  V A   A  + +L  +S +     V E 
Sbjct  169  AVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDEQ  228

Query  234  DVIHLRAGQK------AWFTIAGDPQTRYEGVLKDILPTPEKINDAIFYYARFEVPNPKR  287
              +   + Q+       +  +A +     EG +  I       +  I   A F+  NP  
Sbjct  229  TYLKYISNQRNSSQVPVYMGLANETGFTREGTINSIDNNLNTTSGTIRVRATFD--NPNG  286

Query  288  ILRLDMTAQVYIQLMDVKNVLIIPLAALGEPVGGNRYKVALLRNGEKREREVVIGERNDT  347
            +L   + A++ +     +  ++I   A+G      R+ V +    +   REV +G + D 
Sbjct  287  VLLPGLYARIRLGGGQPRPAILISPTAVGVD-QDKRFVVVVDAKNQTAYREVKLGAQQDG  345

Query  348  DVEVVKGLEAGDEVIIG---ESRPG  369
               V  GL+AGD +++      RPG
Sbjct  346  LQIVNSGLQAGDRIVVNGLQRIRPG  370


>VFG037705(gb|WP_000010636) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii ACICU]
Length=406

 Score = 99.4 bits (246),  Expect = 5e-23, Method: Compositional matrix adjust.
 Identities = 91/325 (28%), Positives = 154/325 (47%), Gaps = 26/325 (8%)

Query  54   TGKLDALRKVDVGAQVSGQLKTLLVSIGDNVKKDQLLGVIDPDQAENQIKEVEATLMELN  113
            +G+L+A+ +VD+  QVSG+L  +    G  VKK  LL  IDP       +  EA L    
Sbjct  63   SGRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDP-------RPFEAELNRAK  115

Query  114  AERQQAAAELKLARVTLARQQQLAKTQAVSQQDLDTAATEMAVKQARIGTIDAQIKRNRA  173
            A+   A A++      L+R Q+L ++ AVS+Q+LD     +A   AR  + +A ++  RA
Sbjct  116  AQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELD-----LAENDAR--SANANLQAARA  168

Query  174  SLDTAKTNLEYTRIVAPMAGEVTQITTLQGQTVIAAQQAPNILTLADMSTMLVKAQVSEA  233
            ++ +A+ NLEYTRI AP++G +++     G  V A   A  + +L  +S +     V E 
Sbjct  169  AVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDEQ  228

Query  234  DVIHLRAGQK------AWFTIAGDPQTRYEGVLKDILPTPEKINDAIFYYARFEVPNPKR  287
              +   + Q+       +  +A +     EG +  I       +  I   A F+  NP  
Sbjct  229  TYLKYISNQRNSAQVPVYMGLANETGFTREGTINSIDNNLNTTSGTIRVRATFD--NPNG  286

Query  288  ILRLDMTAQVYIQLMDVKNVLIIPLAALGEPVGGNRYKVALLRNGEKREREVVIGERNDT  347
            +L   + A++ +     +  ++I   A+G      R+ V +    +   REV +G + D 
Sbjct  287  VLLPGLYARIRLGGGQPRPAILISPTAVGVD-QDKRFVVVVDAKNQTAYREVKLGAQQDG  345

Query  348  DVEVVKGLEAGDEVIIG---ESRPG  369
               V  GL+AGD +++      RPG
Sbjct  346  LQIVNSGLQAGDRIVVNGLQRIRPG  370


>VFG037706(gb|YP_001085329) (adeF) membrane-fusion protein [AdeFGH 
efflux pump (VF0504) - Biofilm (VFC0271)] [Acinetobacter 
baumannii ATCC 17978]
Length=381

 Score = 99.0 bits (245),  Expect = 6e-23, Method: Compositional matrix adjust.
 Identities = 91/325 (28%), Positives = 154/325 (47%), Gaps = 26/325 (8%)

Query  54   TGKLDALRKVDVGAQVSGQLKTLLVSIGDNVKKDQLLGVIDPDQAENQIKEVEATLMELN  113
            +G+L+A+ +VD+  QVSG+L  +    G  VKK  LL  IDP       +  EA L    
Sbjct  39   SGRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDP-------RPFEAELNRAK  91

Query  114  AERQQAAAELKLARVTLARQQQLAKTQAVSQQDLDTAATEMAVKQARIGTIDAQIKRNRA  173
            A+   A A++      L+R Q+L ++ AVS+Q+LD     +A   AR  + +A ++  RA
Sbjct  92   AQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELD-----LAENDAR--SANANLQAARA  144

Query  174  SLDTAKTNLEYTRIVAPMAGEVTQITTLQGQTVIAAQQAPNILTLADMSTMLVKAQVSEA  233
            ++ +A+ NLEYTRI AP++G +++     G  V A   A  + +L  +S +     V E 
Sbjct  145  AVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDEQ  204

Query  234  DVIHLRAGQK------AWFTIAGDPQTRYEGVLKDILPTPEKINDAIFYYARFEVPNPKR  287
              +   + Q+       +  +A +     EG +  I       +  I   A F+  NP  
Sbjct  205  TYLKYISNQRNSAQVPVYMGLANETGFTREGTINSIDNNLNTTSGTIRVRATFD--NPNG  262

Query  288  ILRLDMTAQVYIQLMDVKNVLIIPLAALGEPVGGNRYKVALLRNGEKREREVVIGERNDT  347
            +L   + A++ +     +  ++I   A+G      R+ V +    +   REV +G + D 
Sbjct  263  VLLPGLYARIRLGGGQPRPAILISPTAVGVD-QDKRFVVVVDAKNQTAYREVKLGAQQDG  321

Query  348  DVEVVKGLEAGDEVIIG---ESRPG  369
               V  GL+AGD +++      RPG
Sbjct  322  LQIVNSGLQAGDRIVVNGLQRIRPG  346


>VFG036982(gb|WP_002224350) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis alpha710]
Length=412

 Score = 89.0 bits (219),  Expect = 2e-19, Method: Compositional matrix adjust.
 Identities = 101/353 (29%), Positives = 156/353 (44%), Gaps = 31/353 (9%)

Query  22   GGMAGWRMINAPLPTYQTLIVRPGDLEQSVLATGKLDALRKVDVGAQVSGQLKTLLVSIG  81
            GG    R   AP P    + V P  +  +V   G+L++LR  DV AQV G ++  L   G
Sbjct  34   GGQPAGR--EAPAPVVGVVTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEG  91

Query  82   DNVKKDQLLGVIDPDQAENQIKEVEATLMELNAERQQAAAELKLARVTLARQQQLAKTQA  141
              V+  Q L  ID           EA L    A+   A A L  A   LAR + L   +A
Sbjct  92   SYVRAGQPLYQIDSS-------TYEANLESARAQLATAQATLAKADADLARYKPLVAAEA  144

Query  142  VSQQDLDTAATEMAVKQARIGTIDAQIKRNRASLDTAKTNLEYTRIVAPMAGEVTQITTL  201
            VS+Q+ D A T  A + A  G     +K  +A++ +A  NL  +RI AP++G + Q    
Sbjct  145  VSRQEYDAAVT--AKRSAEAG-----VKAAQAAIKSAGINLNRSRITAPISGFIGQSKVS  197

Query  202  QGQTVIAAQQAPNILTLADMSTMLVKAQVSEADVIHLRAGQKAWFTIAGDPQTRYEGVLK  261
            +G T++ A     + T+   + M V    S ++V+ LR        +A D          
Sbjct  198  EG-TLLNAGDTTVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGKLLAADGVIAVGIKFD  256

Query  262  DILPTPEK---------INDAIFYYA-RFEVPNPKRILRLDMTAQVYIQLMDVKNVLIIP  311
            D    PEK         +N++      R  VPN + IL   +  +V +  + V N  I+P
Sbjct  257  DGTVYPEKGRLLFADPAVNESTGQITLRAAVPNDQNILMPGLYVRVLMDQVAVDNAFIVP  316

Query  312  LAALGEPVGGNRYKVALLR-NGEKREREVVIGERNDTDVEVVKGLEAGDEVII  363
              A+     G +  V ++   G    REV + ++  T+  V  GL+ GD+V++
Sbjct  317  QQAVTR---GAKDTVMIVNAQGGMEPREVTVAQQQGTNWIVTSGLKDGDKVVV  366


>VFG036980(gb|WP_014573842) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis 8013]
Length=412

 Score = 89.0 bits (219),  Expect = 2e-19, Method: Compositional matrix adjust.
 Identities = 101/353 (29%), Positives = 156/353 (44%), Gaps = 31/353 (9%)

Query  22   GGMAGWRMINAPLPTYQTLIVRPGDLEQSVLATGKLDALRKVDVGAQVSGQLKTLLVSIG  81
            GG    R   AP P    + V P  +  +V   G+L++LR  DV AQV G ++  L   G
Sbjct  34   GGQPAGR--EAPAPVVGVVTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEG  91

Query  82   DNVKKDQLLGVIDPDQAENQIKEVEATLMELNAERQQAAAELKLARVTLARQQQLAKTQA  141
              V+  Q L  ID           EA L    A+   A A L  A   LAR + L   +A
Sbjct  92   SYVRAGQPLYQIDSS-------TYEANLESARAQLATAQATLAKADADLARYKPLVAAEA  144

Query  142  VSQQDLDTAATEMAVKQARIGTIDAQIKRNRASLDTAKTNLEYTRIVAPMAGEVTQITTL  201
            VS+Q+ D A T  A + A  G     +K  +A++ +A  NL  +RI AP++G + Q    
Sbjct  145  VSRQEYDAAVT--AKRSAEAG-----VKAAQAAIKSAGINLNRSRITAPISGFIGQSKVS  197

Query  202  QGQTVIAAQQAPNILTLADMSTMLVKAQVSEADVIHLRAGQKAWFTIAGDPQTRYEGVLK  261
            +G T++ A     + T+   + M V    S ++V+ LR        +A D          
Sbjct  198  EG-TLLNAGDTTVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGKLLAADGVIAVGIKFD  256

Query  262  DILPTPEK---------INDAIFYYA-RFEVPNPKRILRLDMTAQVYIQLMDVKNVLIIP  311
            D    PEK         +N++      R  VPN + IL   +  +V +  + V N  I+P
Sbjct  257  DGTVYPEKGRLLFADPTVNESTGQITLRAAVPNDQNILMPGLYVRVLMDQVAVDNAFIVP  316

Query  312  LAALGEPVGGNRYKVALLR-NGEKREREVVIGERNDTDVEVVKGLEAGDEVII  363
              A+     G +  V ++   G    REV + ++  T+  V  GL+ GD+V++
Sbjct  317  QQAVTR---GAKDTVMIVNAQGGMEPREVTVAQQQGTNWIVTSGLKDGDKVVV  366


>VFG036984(gb|WP_014580972) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis M01-240149]
Length=412

 Score = 88.6 bits (218),  Expect = 3e-19, Method: Compositional matrix adjust.
 Identities = 100/353 (28%), Positives = 156/353 (44%), Gaps = 31/353 (9%)

Query  22   GGMAGWRMINAPLPTYQTLIVRPGDLEQSVLATGKLDALRKVDVGAQVSGQLKTLLVSIG  81
            GG    R   AP P    + V P  +  +V   G+L++LR  DV AQV G ++  L   G
Sbjct  34   GGQPAGR--EAPAPVVGVVTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEG  91

Query  82   DNVKKDQLLGVIDPDQAENQIKEVEATLMELNAERQQAAAELKLARVTLARQQQLAKTQA  141
              V+  Q L  ID           EA L    A+   A A L  A   LAR + L   +A
Sbjct  92   SYVRAGQPLYQIDSS-------TYEANLESARAQLATAQATLAKADADLARYKPLVAAEA  144

Query  142  VSQQDLDTAATEMAVKQARIGTIDAQIKRNRASLDTAKTNLEYTRIVAPMAGEVTQITTL  201
            VS+Q+ D A T  A + A  G     +K  +A++ +A  NL  +RI AP++G + Q    
Sbjct  145  VSRQEYDAAVT--AKRSAEAG-----VKAAQAAIKSAGINLNRSRITAPISGFIGQSKVS  197

Query  202  QGQTVIAAQQAPNILTLADMSTMLVKAQVSEADVIHLRAGQKAWFTIAGDPQTRYEGVLK  261
            +G T++ A     + T+   + M V    S ++V+ LR        +A D          
Sbjct  198  EG-TLLNAGDTTVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGKLLAADGVIAVGIKFD  256

Query  262  DILPTPEK---------INDAIFYYA-RFEVPNPKRILRLDMTAQVYIQLMDVKNVLIIP  311
            D    PEK         +N++      R  VPN + IL   +  +V +  + V N  ++P
Sbjct  257  DGTVYPEKGRLLFADPAVNESTGQITLRAAVPNDQNILMPGLYVRVLMDQVAVDNAFVVP  316

Query  312  LAALGEPVGGNRYKVALLR-NGEKREREVVIGERNDTDVEVVKGLEAGDEVII  363
              A+     G +  V ++   G    REV + ++  T+  V  GL+ GD+V++
Sbjct  317  QQAVTR---GAKDTVMIVNAQGGMEPREVTVAQQQGTNWIVTSGLKDGDKVVV  366


>VFG036973(gb|WP_002222106) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis Z2491]
Length=412

 Score = 88.6 bits (218),  Expect = 3e-19, Method: Compositional matrix adjust.
 Identities = 101/353 (29%), Positives = 156/353 (44%), Gaps = 31/353 (9%)

Query  22   GGMAGWRMINAPLPTYQTLIVRPGDLEQSVLATGKLDALRKVDVGAQVSGQLKTLLVSIG  81
            GG    R   AP P    + V P  +  +V   G+L++LR  DV AQV G ++  L   G
Sbjct  34   GGQPAGR--EAPAPVVGVVTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEG  91

Query  82   DNVKKDQLLGVIDPDQAENQIKEVEATLMELNAERQQAAAELKLARVTLARQQQLAKTQA  141
              V+  Q L  ID           EA L    A+   A A L  A   LAR + L   +A
Sbjct  92   SYVRAGQPLYQIDSS-------TYEAGLESARAQLATAQATLAKADADLARYKPLVAAEA  144

Query  142  VSQQDLDTAATEMAVKQARIGTIDAQIKRNRASLDTAKTNLEYTRIVAPMAGEVTQITTL  201
            VS+Q+ D A T  A + A  G     +K  +A++ +A  NL  +RI AP++G + Q    
Sbjct  145  VSRQEYDAAVT--AKRSAEAG-----VKAAQAAIKSAGINLNRSRITAPISGFIGQSKVS  197

Query  202  QGQTVIAAQQAPNILTLADMSTMLVKAQVSEADVIHLRAGQKAWFTIAGDPQTRYEGVLK  261
            +G T++ A     + T+   + M V    S ++V+ LR        +A D          
Sbjct  198  EG-TLLNAGDTTVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGKLLAADGVIAVGIKFD  256

Query  262  DILPTPEK---------INDAIFYYA-RFEVPNPKRILRLDMTAQVYIQLMDVKNVLIIP  311
            D    PEK         +N++      R  VPN + IL   +  +V +  + V N  I+P
Sbjct  257  DGTVYPEKGRLLFADPTVNESTGQITLRAAVPNDQNILMPGLYVRVLMDQVAVDNAFIVP  316

Query  312  LAALGEPVGGNRYKVALLR-NGEKREREVVIGERNDTDVEVVKGLEAGDEVII  363
              A+     G +  V ++   G    REV + ++  T+  V  GL+ GD+V++
Sbjct  317  QQAVTR---GAKDTVMIVNAQGGMEPREVTVAQQQGTNWIVTSGLKDGDKVVV  366


>VFG036981(gb|WP_002232912) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis alpha14]
Length=412

 Score = 88.2 bits (217),  Expect = 3e-19, Method: Compositional matrix adjust.
 Identities = 100/353 (28%), Positives = 156/353 (44%), Gaps = 31/353 (9%)

Query  22   GGMAGWRMINAPLPTYQTLIVRPGDLEQSVLATGKLDALRKVDVGAQVSGQLKTLLVSIG  81
            GG    R   AP P    + V P  +  +V   G+L++LR  DV AQV G ++  L   G
Sbjct  34   GGQPAGR--EAPAPVVGVVTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEG  91

Query  82   DNVKKDQLLGVIDPDQAENQIKEVEATLMELNAERQQAAAELKLARVTLARQQQLAKTQA  141
              V+  Q L  ID           EA L    A+   A A L  A   LAR + L   +A
Sbjct  92   SYVRAGQPLYQIDSS-------TYEANLESARAQLATAQATLAKADADLARYKPLVAAEA  144

Query  142  VSQQDLDTAATEMAVKQARIGTIDAQIKRNRASLDTAKTNLEYTRIVAPMAGEVTQITTL  201
            VS+Q+ D A T  A + A  G     +K  +A++ +A  NL  +RI AP++G + Q    
Sbjct  145  VSRQEYDAAVT--AKRSAEAG-----VKAAQAAIKSAGINLNRSRITAPISGFIGQSKVS  197

Query  202  QGQTVIAAQQAPNILTLADMSTMLVKAQVSEADVIHLRAGQKAWFTIAGDPQTRYEGVLK  261
            +G T++ A     + T+   + M V    S ++V+ LR        +A D          
Sbjct  198  EG-TLLNAGDTTVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGKLLAADGVIAVGIKFD  256

Query  262  DILPTPEK---------INDAIFYYA-RFEVPNPKRILRLDMTAQVYIQLMDVKNVLIIP  311
            D    PEK         +N++      R  VPN + IL   +  +V +  + V N  ++P
Sbjct  257  DGTVYPEKGRLLFADPTVNESTGQITLRAAVPNDQNILMPGLYVRVLMDQVAVDNAFVVP  316

Query  312  LAALGEPVGGNRYKVALLR-NGEKREREVVIGERNDTDVEVVKGLEAGDEVII  363
              A+     G +  V ++   G    REV + ++  T+  V  GL+ GD+V++
Sbjct  317  QQAVTR---GAKDTVMIVNAQGGMEPREVTVAQQQGTNWIVTSGLKDGDKVVV  366


>VFG036976(gb|WP_002220426) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis FAM18]
Length=412

 Score = 88.2 bits (217),  Expect = 3e-19, Method: Compositional matrix adjust.
 Identities = 101/353 (29%), Positives = 156/353 (44%), Gaps = 31/353 (9%)

Query  22   GGMAGWRMINAPLPTYQTLIVRPGDLEQSVLATGKLDALRKVDVGAQVSGQLKTLLVSIG  81
            GG    R   AP P    + V P  +  +V   G+L++LR  DV AQV G ++  L   G
Sbjct  34   GGQPAGR--EAPAPVVGVVTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEG  91

Query  82   DNVKKDQLLGVIDPDQAENQIKEVEATLMELNAERQQAAAELKLARVTLARQQQLAKTQA  141
              V+  Q L  ID           EA L    A+   A A L  A   LAR + L   +A
Sbjct  92   SYVRAGQPLYQIDSS-------TYEAGLESARAQLATAQATLAKADADLARYKPLVAAEA  144

Query  142  VSQQDLDTAATEMAVKQARIGTIDAQIKRNRASLDTAKTNLEYTRIVAPMAGEVTQITTL  201
            VS+Q+ D A T  A + A  G     +K  +A++ +A  NL  +RI AP++G + Q    
Sbjct  145  VSRQEYDAAVT--AKRSAEAG-----VKAAQAAIKSAGINLNRSRITAPISGFIGQSKVS  197

Query  202  QGQTVIAAQQAPNILTLADMSTMLVKAQVSEADVIHLRAGQKAWFTIAGDPQTRYEGVLK  261
            +G T++ A     + T+   + M V    S ++V+ LR        +A D          
Sbjct  198  EG-TLLNAGDTTVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGKLLAADGVIAVGIKFD  256

Query  262  DILPTPEK---------INDAIFYYA-RFEVPNPKRILRLDMTAQVYIQLMDVKNVLIIP  311
            D    PEK         +N++      R  VPN + IL   +  +V +  + V N  I+P
Sbjct  257  DGTVYPEKGRLLFADPTVNESTGQITLRAAVPNDQNILMPGLYVRVLMDQVAVDNAFIVP  316

Query  312  LAALGEPVGGNRYKVALLR-NGEKREREVVIGERNDTDVEVVKGLEAGDEVII  363
              A+     G +  V ++   G    REV + ++  T+  V  GL+ GD+V++
Sbjct  317  QQAVTR---GAKDTVMIVNAQGGMEPREVTVAQQQGTNWIVTSGLKDGDKVVV  366


>VFG036979(gb|WP_002246382) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis WUE 2594]
Length=412

 Score = 88.2 bits (217),  Expect = 3e-19, Method: Compositional matrix adjust.
 Identities = 100/353 (28%), Positives = 156/353 (44%), Gaps = 31/353 (9%)

Query  22   GGMAGWRMINAPLPTYQTLIVRPGDLEQSVLATGKLDALRKVDVGAQVSGQLKTLLVSIG  81
            GG    R   AP P    + V P  +  +V   G+L++LR  DV AQV G ++  L   G
Sbjct  34   GGQPAGR--EAPAPVVGVVTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEG  91

Query  82   DNVKKDQLLGVIDPDQAENQIKEVEATLMELNAERQQAAAELKLARVTLARQQQLAKTQA  141
              V+  Q L  ID           EA L    A+   A A L  A   LAR + L   +A
Sbjct  92   SYVRAGQPLYQIDSS-------TYEANLESARAQLATAQATLAKADADLARYKPLVAAEA  144

Query  142  VSQQDLDTAATEMAVKQARIGTIDAQIKRNRASLDTAKTNLEYTRIVAPMAGEVTQITTL  201
            VS+Q+ D A T  A + A  G     +K  +A++ +A  NL  +RI AP++G + Q    
Sbjct  145  VSRQEYDAAVT--AKRSAEAG-----VKAAQAAIKSAGINLNRSRITAPISGFIGQSKVS  197

Query  202  QGQTVIAAQQAPNILTLADMSTMLVKAQVSEADVIHLRAGQKAWFTIAGDPQTRYEGVLK  261
            +G T++ A     + T+   + M V    S ++V+ LR        +A D          
Sbjct  198  EG-TLLNAGDTTVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGKLLAADGVIAVGIKFD  256

Query  262  DILPTPEK---------INDAIFYYA-RFEVPNPKRILRLDMTAQVYIQLMDVKNVLIIP  311
            D    PEK         +N++      R  VPN + IL   +  +V +  + V N  ++P
Sbjct  257  DGTVYPEKGRLLFADPTVNESTGQITLRAAVPNDQNILMPGLYVRVLMDQVAVDNAFVVP  316

Query  312  LAALGEPVGGNRYKVALLR-NGEKREREVVIGERNDTDVEVVKGLEAGDEVII  363
              A+     G +  V ++   G    REV + ++  T+  V  GL+ GD+V++
Sbjct  317  QQAVTR---GAKDTVMIVNAQGGMEPREVTVAQQQGTNWIVTSGLKDGDKVVV  366


>VFG036983(gb|WP_002216627) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis G2136]
Length=412

 Score = 88.2 bits (217),  Expect = 4e-19, Method: Compositional matrix adjust.
 Identities = 100/353 (28%), Positives = 156/353 (44%), Gaps = 31/353 (9%)

Query  22   GGMAGWRMINAPLPTYQTLIVRPGDLEQSVLATGKLDALRKVDVGAQVSGQLKTLLVSIG  81
            GG    R   AP P    + V P  +  +V   G+L++LR  DV AQV G ++  L   G
Sbjct  34   GGQPAGR--EAPAPVVGVVTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEG  91

Query  82   DNVKKDQLLGVIDPDQAENQIKEVEATLMELNAERQQAAAELKLARVTLARQQQLAKTQA  141
              V+  Q L  ID           EA L    A+   A A L  A   LAR + L   +A
Sbjct  92   SYVRAGQPLYQIDSS-------TYEANLESARAQLATAQATLAKADADLARYKPLVAAEA  144

Query  142  VSQQDLDTAATEMAVKQARIGTIDAQIKRNRASLDTAKTNLEYTRIVAPMAGEVTQITTL  201
            VS+Q+ D A T  A + A  G     +K  +A++ +A  NL  +RI AP++G + Q    
Sbjct  145  VSRQEYDAAVT--AKRSAEAG-----VKAAQAAIKSAGINLNRSRITAPISGFIGQSKVS  197

Query  202  QGQTVIAAQQAPNILTLADMSTMLVKAQVSEADVIHLRAGQKAWFTIAGDPQTRYEGVLK  261
            +G T++ A     + T+   + M V    S ++V+ LR        +A D          
Sbjct  198  EG-TLLNAGDTTVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGKLLAADGVIAVGIKFD  256

Query  262  DILPTPEK---------INDAIFYYA-RFEVPNPKRILRLDMTAQVYIQLMDVKNVLIIP  311
            D    PEK         +N++      R  VPN + IL   +  +V +  + V N  ++P
Sbjct  257  DGTVYPEKGRLLFADPVVNESTGQITLRAAVPNDQNILMPGLYVRVLMDQVAVDNAFVVP  316

Query  312  LAALGEPVGGNRYKVALLR-NGEKREREVVIGERNDTDVEVVKGLEAGDEVII  363
              A+     G +  V ++   G    REV + ++  T+  V  GL+ GD+V++
Sbjct  317  QQAVTR---GAKDTVMIVNAQGGMEPREVTVAQQQGTNWIVTSGLKDGDKVVV  366


>VFG036987(gb|WP_014582209) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis M01-240355]
Length=412

 Score = 87.8 bits (216),  Expect = 5e-19, Method: Compositional matrix adjust.
 Identities = 99/353 (28%), Positives = 156/353 (44%), Gaps = 31/353 (9%)

Query  22   GGMAGWRMINAPLPTYQTLIVRPGDLEQSVLATGKLDALRKVDVGAQVSGQLKTLLVSIG  81
            GG    R   AP P    + V P  +  +V   G+L++LR  DV AQV G ++  L   G
Sbjct  34   GGQPAGR--EAPAPVVGVVTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEG  91

Query  82   DNVKKDQLLGVIDPDQAENQIKEVEATLMELNAERQQAAAELKLARVTLARQQQLAKTQA  141
              V+  Q L  ID           EA+L    A+   A A L  A   LAR + L    A
Sbjct  92   SYVRAGQPLYQIDSS-------TYEASLESARAQLATAQATLAKADADLARYKPLVAADA  144

Query  142  VSQQDLDTAATEMAVKQARIGTIDAQIKRNRASLDTAKTNLEYTRIVAPMAGEVTQITTL  201
            +S+Q+ D A T  A + A  G     +K  +A++ +A  +L  +RI AP++G + Q    
Sbjct  145  ISKQEYDAAVT--AKRSAEAG-----VKAAQAAIKSAGISLNRSRITAPISGFIGQSKVS  197

Query  202  QGQTVIAAQQAPNILTLADMSTMLVKAQVSEADVIHLRAGQKAWFTIAGDPQTRYEGVLK  261
            +G T++ A  A  + T+   + M V    S ++V+ LR        +A D          
Sbjct  198  EG-TLLNAGDATVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGKLLAADGAVAVGIKFD  256

Query  262  DILPTPEK---------INDAIFYYA-RFEVPNPKRILRLDMTAQVYIQLMDVKNVLIIP  311
            D    PEK         +N++      R  VPN + IL   +  +V +  + V N  I+P
Sbjct  257  DGTVYPEKGRLLFADPTVNESTGQITLRAAVPNDQNILMPGLYVRVLMDQVAVDNAFIVP  316

Query  312  LAALGEPVGGNRYKVALLR-NGEKREREVVIGERNDTDVEVVKGLEAGDEVII  363
              A+     G +  V ++   G    REV + ++   +  V  GL+ GD+V++
Sbjct  317  QQAVTR---GTKDTVIIVNAQGGMEPREVTVAQQQGANWIVTSGLKDGDKVVV  366


>VFG036974(gb|WP_002224968) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria meningitidis MC58]
Length=412

 Score = 87.4 bits (215),  Expect = 6e-19, Method: Compositional matrix adjust.
 Identities = 97/343 (28%), Positives = 154/343 (45%), Gaps = 29/343 (8%)

Query  32   APLPTYQTLIVRPGDLEQSVLATGKLDALRKVDVGAQVSGQLKTLLVSIGDNVKKDQLLG  91
            AP P    + V P  +  +V   G+L++LR  DV AQV G ++  L   G  V+  Q L 
Sbjct  42   APAPVVGVVTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLY  101

Query  92   VIDPDQAENQIKEVEATLMELNAERQQAAAELKLARVTLARQQQLAKTQAVSQQDLDTAA  151
             ID           EA L    A+   A A L  A   LAR + L   +AVS+Q+ D A 
Sbjct  102  QIDSS-------TYEAGLESARAQLATAQATLAKADADLARYKPLVAAEAVSRQEYDAAV  154

Query  152  TEMAVKQARIGTIDAQIKRNRASLDTAKTNLEYTRIVAPMAGEVTQITTLQGQTVIAAQQ  211
            T  A + A  G     +K  +A++ +A  +L  +RI AP++G + Q    +G T++ A  
Sbjct  155  T--AKRSAEAG-----VKAAQAAIKSAGISLNRSRITAPISGFIGQSKVSEG-TLLNAGD  206

Query  212  APNILTLADMSTMLVKAQVSEADVIHLRAGQKAWFTIAGDPQTRYEGVLKDILPTPEK--  269
            A  + T+   + M V    S ++V+ LR        +A D          D    PEK  
Sbjct  207  ATVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGKLLAADGVIAVGIKFDDGTVYPEKGR  266

Query  270  -------INDAIFYYA-RFEVPNPKRILRLDMTAQVYIQLMDVKNVLIIPLAALGEPVGG  321
                   +N++      R  VPN + IL   +  +V +  + V N  ++P  A+     G
Sbjct  267  LLFADPAVNESTGQITLRAAVPNDQNILMPGLYVRVLMDQVAVDNAFVVPQQAVTR---G  323

Query  322  NRYKVALLR-NGEKREREVVIGERNDTDVEVVKGLEAGDEVII  363
             +  V ++   G    REV + ++  T+  V  GL+ GD+V++
Sbjct  324  AKDTVMIVNAQGGMEPREVTVAQQQGTNWIVTSGLKDGDKVVV  366


>VFG036990(gb|WP_013448559) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria lactamica 020-06]
Length=412

 Score = 85.9 bits (211),  Expect = 2e-18, Method: Compositional matrix adjust.
 Identities = 99/353 (28%), Positives = 155/353 (44%), Gaps = 31/353 (9%)

Query  22   GGMAGWRMINAPLPTYQTLIVRPGDLEQSVLATGKLDALRKVDVGAQVSGQLKTLLVSIG  81
            GG    R   AP P    + V P  +  +V   G+L++LR  DV AQV G ++  L   G
Sbjct  34   GGQPAGR--EAPAPVVGVVTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEG  91

Query  82   DNVKKDQLLGVIDPDQAENQIKEVEATLMELNAERQQAAAELKLARVTLARQQQLAKTQA  141
              V+  Q L  ID           EA L    A+   A A L  A   LAR + L   +A
Sbjct  92   SYVRAGQPLYQIDSS-------TYEAGLESARAQLATAQATLAKADADLARYKPLVAAEA  144

Query  142  VSQQDLDTAATEMAVKQARIGTIDAQIKRNRASLDTAKTNLEYTRIVAPMAGEVTQITTL  201
            VS+Q+ D A T  A + A  G     +K  +A++ +A  NL  +RI AP++G + Q    
Sbjct  145  VSRQEYDAAVT--AKRSAEAG-----VKAAQAAIKSAGINLNRSRITAPISGFIGQSKVS  197

Query  202  QGQTVIAAQQAPNILTLADMSTMLVKAQVSEADVIHLRAGQKAWFTIAGDPQTRYEGVLK  261
            +G T++ A     + T+   + M V    S ++V+ LR        +A D          
Sbjct  198  EG-TLLNAGDTTVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGKLLAADGVIAVGIKFD  256

Query  262  DILPTPEK---------INDAIFYYA-RFEVPNPKRILRLDMTAQVYIQLMDVKNVLIIP  311
            D    PEK         +N++      R  VPN + IL   +  +V +  + V N  ++P
Sbjct  257  DGTVYPEKGRLLFADPTVNESTGQITLRAAVPNDQNILMPGLYVRVLMDQVAVDNAFVVP  316

Query  312  LAALGEPVGGNRYKVALLR-NGEKREREVVIGERNDTDVEVVKGLEAGDEVII  363
              A+     G +  V ++   G    REV + ++   +  V  GL+ GD+V++
Sbjct  317  QQAVTR---GAKDTVMIVNAQGGMEPREVTVAQQQGANWIVTSGLKDGDKVVV  366


>VFG036975(gb|WP_010951249) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria gonorrhoeae FA 1090]
Length=412

 Score = 83.6 bits (205),  Expect = 1e-17, Method: Compositional matrix adjust.
 Identities = 102/355 (29%), Positives = 155/355 (44%), Gaps = 35/355 (10%)

Query  22   GGMAGWRMINAPLPTYQTLIVRPGDLEQSVLATGKLDALRKVDVGAQVSGQLKTLLVSIG  81
            GG    R   AP P    + V P  +  +V   G+L++LR  DV AQV G ++  L   G
Sbjct  34   GGQPAGR--EAPAPVVGVVTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEG  91

Query  82   DNVKKDQLLGVIDPDQAENQIKEVEATLMELNAERQQAAAELKLARVTLARQQQLAKTQA  141
              V+  Q L  ID           EA L    A+   A A L  A   LAR + L    A
Sbjct  92   SYVRAGQPLYQIDSS-------TYEAGLESARAQLATAQATLAKADADLARYKPLVSADA  144

Query  142  VSQQDLDTAATEMAVKQARIGTIDAQIKRNRASLDTAKTNLEYTRIVAPMAGEVTQITTL  201
            +S+Q+ D A T  A + A  G     +K  +A++ +A  NL  +RI AP++G + Q    
Sbjct  145  ISKQEYDAAVT--AKRSAEAG-----VKAAQAAIKSAGINLNRSRITAPISGFIGQSKVS  197

Query  202  QGQTVIAAQQAPNILTLADMSTMLVKAQVSEADVIHLR----------AGQKAWFTIAGD  251
            +G T++ A     + T+   + M V    S ++V+ LR          A       I  D
Sbjct  198  EG-TLLNAGDTTVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGKLLAADGAIAVGIKFD  256

Query  252  PQTRY--EGVLKDILPTPEKINDAIFYYARFEVPNPKRILRLDMTAQVYIQLMDVKNVLI  309
              T Y  +G L    PT E+    I    R  V N + IL   +  +V +  +   N  I
Sbjct  257  DGTVYPEKGRLLFADPTVEESTGQITL--RAAVSNDQNILMPGLYVRVLMDQVAADNAFI  314

Query  310  IPLAALGEPVGGNRYKVALLR-NGEKREREVVIGERNDTDVEVVKGLEAGDEVII  363
            +P  A+     G +  V ++   G    REV + ++  T+  V  GL+ GD+V++
Sbjct  315  VPQQAVTR---GAKDTVMIVNAQGGMEPREVTVAQQQGTNWIVTSGLKDGDKVVV  366


>VFG036978(gb|WP_004465401) (mtrC) membrane fusion protein MtrC 
[MtrCDE (VF0451) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Neisseria gonorrhoeae NCCP11945]
Length=412

 Score = 82.4 bits (202),  Expect = 3e-17, Method: Compositional matrix adjust.
 Identities = 101/355 (28%), Positives = 155/355 (44%), Gaps = 35/355 (10%)

Query  22   GGMAGWRMINAPLPTYQTLIVRPGDLEQSVLATGKLDALRKVDVGAQVSGQLKTLLVSIG  81
            GG    R   AP P    + V P  +  +V   G+L++LR  DV AQV G ++  L   G
Sbjct  34   GGQPAGR--EAPAPVVGVVTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEG  91

Query  82   DNVKKDQLLGVIDPDQAENQIKEVEATLMELNAERQQAAAELKLARVTLARQQQLAKTQA  141
              V+  Q L  ID           EA L    A+   A A L  A   LAR + L    A
Sbjct  92   SYVRAGQPLYQIDSS-------TYEAGLESARAQLATAQATLAKADADLARYKPLVSADA  144

Query  142  VSQQDLDTAATEMAVKQARIGTIDAQIKRNRASLDTAKTNLEYTRIVAPMAGEVTQITTL  201
            +S+Q+ D A T  A + A  G     +K  +A++ +A  NL  +RI AP++G + Q    
Sbjct  145  ISKQEYDAAVT--AKRSAEAG-----VKAAQAAIKSAGINLNRSRITAPISGFIGQSKVS  197

Query  202  QGQTVIAAQQAPNILTLADMSTMLVKAQVSEADVIHLR----------AGQKAWFTIAGD  251
            +G T++ A     + T+   + M V    S ++V+ LR          A       I  D
Sbjct  198  EG-TLLNAGDTTVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGKLLAADGAIAVGIKFD  256

Query  252  PQTRY--EGVLKDILPTPEKINDAIFYYARFEVPNPKRILRLDMTAQVYIQLMDVKNVLI  309
              T Y  +G L    PT ++    I    R  V N + IL   +  +V +  +   N  I
Sbjct  257  DGTVYPEKGRLLFADPTVDESTGQITL--RAAVSNDQNILMPGLYVRVLMDQVAADNAFI  314

Query  310  IPLAALGEPVGGNRYKVALLR-NGEKREREVVIGERNDTDVEVVKGLEAGDEVII  363
            +P  A+     G +  V ++   G    REV + ++  T+  V  GL+ GD+V++
Sbjct  315  VPQQAVTR---GAKDTVMIVNAQGGMEPREVTVAQQQGTNWIVTSGLKDGDKVVV  366


>VFG049129(gb|YP_005225489) (acrA) acriflavine resistance protein 
A [AcrAB (VF0568) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Klebsiella pneumoniae subsp. pneumoniae 
HS11286]
Length=397

 Score = 55.1 bits (131),  Expect = 3e-08, Method: Compositional matrix adjust.
 Identities = 86/368 (23%), Positives = 161/368 (44%), Gaps = 38/368 (10%)

Query  16   ILILLVGGMAGWRMINAP-------LPTYQTLIVRPGDLEQSVLATGKLDALRKVDVGAQ  68
            ++++L G +A     + P       +P    + ++   L+ +    G+  A R  +V  Q
Sbjct  12   VVLMLSGSLALTGCDDKPAQQGAQHMPEVGIVTLKSAPLQITTELPGRTSAYRIAEVRPQ  71

Query  69   VSGQLKTLLVSIGDNVKKDQLLGVIDPDQAENQIKEVEATLMELNAERQQAAAELKLARV  128
            VSG +       G +++    L  IDP   +      +  L      + QAAA +   ++
Sbjct  72   VSGIILKRNFVEGSDIQAGVSLYQIDPATYQASYDSAKGDLA-----KAQAAANMD--QL  124

Query  129  TLARQQQLAKTQAVSQQDLDTAATEMAVKQARIGTIDAQIKRNRASLDTAKTNLEYTRIV  188
            T+ R Q+L  T+ +SQQD DTA   +A  Q      +A +   +A+++TA+ NL YT++ 
Sbjct  125  TVKRYQKLLGTKYISQQDYDTA---VATAQQS----NAAVVAAKAAVETARINLAYTKVT  177

Query  189  APMAGEVTQITTLQGQTVIAAQQAPNILTLADMSTMLVKAQVSEADVIHLR---------  239
            +P++G + + T  +G  ++   Q   + T+  +  + V    S  D + L+         
Sbjct  178  SPISGRIGKSTVTEG-ALVQNGQTTALATVQQLDPIYVDVTQSSNDFLRLKQELADGRLK  236

Query  240  -AGQKAWFTIAGDPQTRY--EGVLKDILPTPEKINDAIFYYARFEVPNPKRILRLDMTAQ  296
                KA   +  +   +Y   G L+    T ++   +I   A F  PNP   L   M  +
Sbjct  237  QENGKAKVELVTNDGLKYPQSGTLEFSDVTVDQTTGSITLRAIF--PNPDHTLLPGMFVR  294

Query  297  VYIQLMDVKNVLIIPLAALGEPVGGNRYKVALLRNGEKRE-REVVIGERNDTDVEVVKGL  355
              ++     + L++P   +     G+   V ++  G+K E R+V   +       V  GL
Sbjct  295  ARLEEGINPDALLVPQQGVTRTPRGDA-SVMVVGEGDKVEVRQVTASQAIGDKWLVTDGL  353

Query  356  EAGDEVII  363
            ++GD VI+
Sbjct  354  KSGDRVIV  361


>VFG049125(gb|WP_004136054) (acrA) acriflavine resistance protein 
A [AcrAB (VF0568) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Klebsiella oxytoca E718]
Length=397

 Score = 53.9 bits (128),  Expect = 6e-08, Method: Compositional matrix adjust.
 Identities = 86/377 (23%), Positives = 164/377 (44%), Gaps = 41/377 (11%)

Query  16   ILILLVGGMAGWRMINAP-------LPTYQTLIVRPGDLEQSVLATGKLDALRKVDVGAQ  68
            ++++L G +A     + P       +P    + ++   L+ +    G+  A R  +V  Q
Sbjct  12   VVLMLSGSLALTGCDDKPAQQGAQQMPEVGIVTLKSAPLQITTELPGRTSAYRVAEVRPQ  71

Query  69   VSGQLKTLLVSIGDNVKKDQLLGVIDPDQAENQIKEVEATLMELNAERQQAAAELKLARV  128
            VSG +     + G +++    L  IDP          +AT      +  +A A   + ++
Sbjct  72   VSGIILKRNFTEGSDIQAGVSLYQIDP-------ATYQATYESAKGDLAKAQAAANMDQL  124

Query  129  TLARQQQLAKTQAVSQQDLDTAATEMAVKQARIGTIDAQIKRNRASLDTAKTNLEYTRIV  188
            T+ R Q+L  T+ +SQQD DTA   +A  Q      +A +   +A+++TA+ NL YT++ 
Sbjct  125  TVKRYQKLLGTKYISQQDYDTA---VATAQQS----NAAVVAAKAAVETARINLAYTKVT  177

Query  189  APMAGEVTQITTLQGQTVIAAQQAPNILTLADMSTMLVKAQVSEADVIHLR---------  239
            +P++G + +    +G  ++   Q   + T+  +  + V    S  D + L+         
Sbjct  178  SPISGRIGKSAVTEG-ALVQNGQTTALATVQQLDPIYVDVTQSSNDFLRLKQELANGKLQ  236

Query  240  -AGQKAWFTIAGDPQTRY--EGVLKDILPTPEKINDAIFYYARFEVPNPKRILRLDMTAQ  296
                KA   +  +   +Y   G L+    T ++   +I   A F  PNP   L   M  +
Sbjct  237  QENGKAKVELVTNDGLKYPQNGTLEFSDVTVDQTTGSITLRAIF--PNPDHTLLPGMFVR  294

Query  297  VYIQLMDVKNVLIIPLAALGEPVGGNRYKVALLRNGEKRE-REVVIGERNDTDVEVVKGL  355
              ++     + L++P   +     G+   + ++  G+K E R++   +       V +GL
Sbjct  295  ARLEEGVNPDALLVPQQGVTRTPRGDASAM-VVGEGDKVEVRQITATQAIGDKWLVTEGL  353

Query  356  EAGDEVIIG---ESRPG  369
            + GD VII    + RPG
Sbjct  354  KTGDRVIITGLQKVRPG  370


>VFG049133(gb|WP_004177236) (acrA) acriflavine resistance protein 
A [AcrAB (VF0568) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Klebsiella pneumoniae subsp. pneumoniae 
NTUH-K2044]
Length=397

 Score = 53.1 bits (126),  Expect = 1e-07, Method: Compositional matrix adjust.
 Identities = 85/368 (23%), Positives = 160/368 (43%), Gaps = 38/368 (10%)

Query  16   ILILLVGGMAGWRMINAP-------LPTYQTLIVRPGDLEQSVLATGKLDALRKVDVGAQ  68
            ++++L G +A     + P       +P    + ++   L+ +    G+  A R  +V  Q
Sbjct  12   VVLMLSGSLALTGCDDKPAQQGAQHMPEVGIVTLKSAPLQITTELPGRTSAYRIAEVRPQ  71

Query  69   VSGQLKTLLVSIGDNVKKDQLLGVIDPDQAENQIKEVEATLMELNAERQQAAAELKLARV  128
            VSG +       G +++    L  IDP   +      +  L      + QAAA +   ++
Sbjct  72   VSGIILKRNFVEGSDIQAGVSLYQIDPATYQASYDSAKGDLA-----KAQAAANMD--QL  124

Query  129  TLARQQQLAKTQAVSQQDLDTAATEMAVKQARIGTIDAQIKRNRASLDTAKTNLEYTRIV  188
            T+ R Q+L  T+ +SQQD DTA   +A  Q      +A +   +A+++TA+ NL YT++ 
Sbjct  125  TVKRYQKLLGTKYISQQDYDTA---VATAQQS----NAAVVAAKAAVETARINLAYTKVT  177

Query  189  APMAGEVTQITTLQGQTVIAAQQAPNILTLADMSTMLVKAQVSEADVIHLR---------  239
            +P++G + +    +G  ++   Q   + T+  +  + V    S  D + L+         
Sbjct  178  SPISGRIGKSAVTEG-ALVQNGQTTALATVQQLDPIYVDVTQSSNDFLRLKQELADGRLK  236

Query  240  -AGQKAWFTIAGDPQTRY--EGVLKDILPTPEKINDAIFYYARFEVPNPKRILRLDMTAQ  296
                KA   +  +   +Y   G L+    T ++   +I   A F  PNP   L   M  +
Sbjct  237  QENGKAKVELVTNDGLKYPQSGTLEFSDVTVDQTTGSITLRAIF--PNPDHTLLPGMFVR  294

Query  297  VYIQLMDVKNVLIIPLAALGEPVGGNRYKVALLRNGEKRE-REVVIGERNDTDVEVVKGL  355
              ++     + L++P   +     G+   V ++  G+K E R+V   +       V  GL
Sbjct  295  ARLEEGINPDALLVPQQGVTRTPRGDA-SVMVVGEGDKVEVRQVTASQAIGDKWLVTDGL  353

Query  356  EAGDEVII  363
            ++GD VI+
Sbjct  354  KSGDRVIV  361


>VFG036954(gb|WP_013448426) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria lactamica 020-06]
Length=390

 Score = 52.4 bits (124),  Expect = 2e-07, Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 98/219 (45%), Gaps = 36/219 (16%)

Query  59   ALRKVDVGAQVSGQLKTLLVSIGDNVKKDQLLGVIDPD-------QAENQIKEVEATLME  111
            A R V V  Q  G ++ +L    D VKK  +L V+D D       +A+N++ +       
Sbjct  61   AGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQAVRQNRR  120

Query  112  LNAERQQAAAELKLARVTLARQQQ-------LAKTQAVSQQDL---------------DT  149
             NA   QAAA++ L R  LAR Q        LA++ AVS ++L                 
Sbjct  121  QNAATSQAAAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQAAVKAA  180

Query  150  AATEMAVKQARIGTID----AQIKRNRASLDTAKTNLEYTRIVAPMAGEVTQITTLQGQT  205
             A E + + A  G +      +++     L  A  NL+ T+I AP  G+V + +   GQ 
Sbjct  181  LAEESSARAALGGQVSLREQPEVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQ  240

Query  206  VIAAQQAPNILTLADMSTMLVKAQVSEADVIHLRAGQKA  244
            V A   AP ++ +  +S M V A   E  + H++ GQ A
Sbjct  241  VAAG--AP-LMAVVPLSDMWVDANFKETQLRHMKIGQPA  276


>VFG049128(gb|WP_012542667) (acrA) acriflavine resistance protein 
A [AcrAB (VF0568) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Klebsiella pneumoniae 342]
Length=397

 Score = 52.0 bits (123),  Expect = 2e-07, Method: Compositional matrix adjust.
 Identities = 85/368 (23%), Positives = 159/368 (43%), Gaps = 38/368 (10%)

Query  16   ILILLVGGMAGWRMINAP-------LPTYQTLIVRPGDLEQSVLATGKLDALRKVDVGAQ  68
            ++++L G +A     + P       +P    + ++   L+ +    G+  A R  +V  Q
Sbjct  12   VVLMLSGSLALTGCDDKPAQQGAQHMPEVGIVTLKSAPLQITTELPGRTSAYRIAEVRPQ  71

Query  69   VSGQLKTLLVSIGDNVKKDQLLGVIDPDQAENQIKEVEATLMELNAERQQAAAELKLARV  128
            VSG +       G +++    L  IDP   +      +  L      + QAAA +   ++
Sbjct  72   VSGIILKRNFVEGSDIQAGVSLYQIDPATYQASYDSAKGDLA-----KAQAAANMD--QL  124

Query  129  TLARQQQLAKTQAVSQQDLDTAATEMAVKQARIGTIDAQIKRNRASLDTAKTNLEYTRIV  188
            T+ R Q+L  T+ +SQQD DTA   +A  Q      +A +   +A+++TA+ NL YT++ 
Sbjct  125  TVKRYQKLLGTKYISQQDYDTA---VATAQQS----NAAVVAAKAAVETARINLAYTKVT  177

Query  189  APMAGEVTQITTLQGQTVIAAQQAPNILTLADMSTMLVKAQVSEADVIHLR---------  239
            +P++G + +    +G  ++   Q   + T+  +  + V    S  D + L+         
Sbjct  178  SPISGRIGKSAVTEG-ALVQNGQTTALATVQQLDPIYVDVTQSSNDFLRLKQELADGRLK  236

Query  240  -AGQKAWFTIAGDPQTRY--EGVLKDILPTPEKINDAIFYYARFEVPNPKRILRLDMTAQ  296
                KA   +  +   +Y   G L+    T ++   +I   A F  PNP   L   M  +
Sbjct  237  QENGKAKVELVTNDGLKYPQAGTLEFSDVTVDQTTGSITLRAIF--PNPDHTLLPGMFVR  294

Query  297  VYIQLMDVKNVLIIPLAALGEPVGGNRYKVALLRNGEKRE-REVVIGERNDTDVEVVKGL  355
              ++     + L++P   +     G+   V ++  G+K E R+V   +       V  GL
Sbjct  295  ARLEEGVNPDALLVPQQGVTRTPRGDA-SVMVVGEGDKVEVRQVTASQAIGDKWLVTDGL  353

Query  356  EAGDEVII  363
            + GD VI+
Sbjct  354  KTGDRVIV  361


>VFG049135(gb|WP_008805438) (acrA) acriflavine resistance protein 
A [AcrAB (VF0568) - Antimicrobial activity/Competitive advantage 
(VFC0325)] [Klebsiella variicola At-22]
Length=397

 Score = 52.0 bits (123),  Expect = 3e-07, Method: Compositional matrix adjust.
 Identities = 85/368 (23%), Positives = 159/368 (43%), Gaps = 38/368 (10%)

Query  16   ILILLVGGMAGWRMINAP-------LPTYQTLIVRPGDLEQSVLATGKLDALRKVDVGAQ  68
            ++++L G +A     + P       +P    + ++   L+ +    G+  A R  +V  Q
Sbjct  12   VVLMLSGSLALTGCDDKPAQQGAQHMPEVGIVTLKSAPLQITTELPGRTSAYRIAEVRPQ  71

Query  69   VSGQLKTLLVSIGDNVKKDQLLGVIDPDQAENQIKEVEATLMELNAERQQAAAELKLARV  128
            VSG +       G +++    L  IDP   +      +  L      + QAAA +   ++
Sbjct  72   VSGIILKRNFVEGSDIQAGVSLYQIDPATYQASYDSAKGDLA-----KAQAAANMD--QL  124

Query  129  TLARQQQLAKTQAVSQQDLDTAATEMAVKQARIGTIDAQIKRNRASLDTAKTNLEYTRIV  188
            T+ R Q+L  T+ +SQQD DTA   +A  Q      +A +   +A+++TA+ NL YT++ 
Sbjct  125  TVKRYQKLLGTKYISQQDYDTA---VATAQQS----NAAVVAAKAAVETARINLAYTKVT  177

Query  189  APMAGEVTQITTLQGQTVIAAQQAPNILTLADMSTMLVKAQVSEADVIHLR---------  239
            +P++G + +    +G  ++   Q   + T+  +  + V    S  D + L+         
Sbjct  178  SPISGRIGKSAVTEG-ALVQNGQTTALATVQQLDPIYVDVTQSSNDFLRLKQELADGRLK  236

Query  240  -AGQKAWFTIAGDPQTRY--EGVLKDILPTPEKINDAIFYYARFEVPNPKRILRLDMTAQ  296
                KA   +  +   +Y   G L+    T ++   +I   A F  PNP   L   M  +
Sbjct  237  QENGKAKVELVTNDGLKYPQAGTLEFSDVTVDQTTGSITLRAIF--PNPDHTLLPGMFVR  294

Query  297  VYIQLMDVKNVLIIPLAALGEPVGGNRYKVALLRNGEKRE-REVVIGERNDTDVEVVKGL  355
              ++     + L++P   +     G+   V ++  G+K E R+V   +       V  GL
Sbjct  295  ARLEEGVNPDALLVPQQGVTRTPRGDA-SVMVVGEGDKVEVRQVTASQAIGDKWLVTDGL  353

Query  356  EAGDEVII  363
            + GD VI+
Sbjct  354  KTGDRVIV  361


>VFG036939(gb|WP_012503946) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria gonorrhoeae FA 1090]
Length=384

 Score = 50.4 bits (119),  Expect = 8e-07, Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 36/219 (16%)

Query  59   ALRKVDVGAQVSGQLKTLLVSIGDNVKKDQLLGVIDPD-------QAENQIKEVEATLME  111
            A R V V  Q  G ++ +L    D VKK  +L V+D D       +A+N++ +       
Sbjct  55   AGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQAVRQNRR  114

Query  112  LNAERQQAAAELKLARVTLARQQQ-------LAKTQAVSQQDLDTAAT------------  152
             NA   QA A++ L R  LAR Q        LA++ AVS ++L  A T            
Sbjct  115  QNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARTAVSQAQAAVKAA  174

Query  153  ---EMAVKQARIGTID----AQIKRNRASLDTAKTNLEYTRIVAPMAGEVTQITTLQGQT  205
               E + + A  G +      +++     L  A  NL  T++ AP  G+V + +   GQ 
Sbjct  175  LAEESSARAALGGDVSLREQPEVQTAIGRLKDAWLNLRRTQVRAPADGQVAKRSVQVGQQ  234

Query  206  VIAAQQAPNILTLADMSTMLVKAQVSEADVIHLRAGQKA  244
            V A   AP ++ +  +S + V A   E  + H++ GQ A
Sbjct  235  VAAG--AP-LMAVVPLSDVWVDANFKETQLRHMKIGQPA  270


>VFG036949(gb|WP_014581326) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M04-240196]
Length=390

 Score = 49.3 bits (116),  Expect = 2e-06, Method: Compositional matrix adjust.
 Identities = 63/219 (29%), Positives = 98/219 (45%), Gaps = 36/219 (16%)

Query  59   ALRKVDVGAQVSGQLKTLLVSIGDNVKKDQLLGVIDPD-------QAENQIKEVEATLME  111
            A R V V  Q  G ++ +L    D VKK  +L V+D D       +A+N++ +       
Sbjct  61   AGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQAVRQNRR  120

Query  112  LNAERQQAAAELKLARVTLARQQQ-------LAKTQAVSQQDL---------------DT  149
             NA   QAAA++ L R  LAR Q        LA++ AVS ++L                 
Sbjct  121  QNAATSQAAAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQAAVKAA  180

Query  150  AATEMAVKQARIGTIDAQ----IKRNRASLDTAKTNLEYTRIVAPMAGEVTQITTLQGQT  205
             A E + + A  G +  +    ++     L  A  NL+ T+I AP  G+V + +   GQ 
Sbjct  181  LAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQ  240

Query  206  VIAAQQAPNILTLADMSTMLVKAQVSEADVIHLRAGQKA  244
            V A   AP ++ +  +S + V A   E  + H++ GQ A
Sbjct  241  VAAG--AP-LMAVVPLSDVWVDANFKETQLRHMKIGQPA  276


>VFG036944(gb|WP_014573758) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 8013]
Length=384

 Score = 48.1 bits (113),  Expect = 4e-06, Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 36/219 (16%)

Query  59   ALRKVDVGAQVSGQLKTLLVSIGDNVKKDQLLGVIDPD-------QAENQIKEVEATLME  111
            A R V V  Q  G ++ +L    D VKK  +L V+D D       +A+N++ +       
Sbjct  55   AGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQAVRQNRR  114

Query  112  LNAERQQAAAELKLARVTLARQQQ-------LAKTQAVSQQDL---------------DT  149
             NA   QA A++ L R  LAR Q        LA++ AVS ++L                 
Sbjct  115  QNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQAAVKAA  174

Query  150  AATEMAVKQARIGTIDAQ----IKRNRASLDTAKTNLEYTRIVAPMAGEVTQITTLQGQT  205
             A E + + A  G +  +    ++     L  A  NL+ T+I AP  G+V + +   GQ 
Sbjct  175  LAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQ  234

Query  206  VIAAQQAPNILTLADMSTMLVKAQVSEADVIHLRAGQKA  244
            V A   AP ++ +  +S + V A   E  + H++ GQ A
Sbjct  235  VAAG--AP-LMAVVPLSDVWVDANFKETQLRHMKIGQPA  270


>VFG036945(gb|WP_015815890) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis alpha14]
Length=390

 Score = 48.1 bits (113),  Expect = 5e-06, Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 36/219 (16%)

Query  59   ALRKVDVGAQVSGQLKTLLVSIGDNVKKDQLLGVIDPD-------QAENQIKEVEATLME  111
            A R V V  Q  G ++ +L    D VKK  +L V+D D       +A+N++ +      +
Sbjct  61   AGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQAVRQNRQ  120

Query  112  LNAERQQAAAELKLARVTLARQQQ-------LAKTQAVSQQDLDTAATEMAVKQARIGTI  164
             NA   QA A++ L R  LAR Q        LA++ AVS ++L  A   ++  QA +   
Sbjct  121  QNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQAAVKAA  180

Query  165  DAQIKRNRAS-------------------LDTAKTNLEYTRIVAPMAGEVTQITTLQGQT  205
             A+    RA+                   L  A  NL+ T+I AP  G+V + +   GQ 
Sbjct  181  LAEESSARAALGGQVALREQPAVQTAIGRLKDAWLNLQRTQIRAPTDGQVAKRSVQVGQQ  240

Query  206  VIAAQQAPNILTLADMSTMLVKAQVSEADVIHLRAGQKA  244
            V A   AP ++ +  +S + V A   E  + H++ GQ A
Sbjct  241  VAAG--AP-LMAVVPLSDVWVDANFKETQLRHMKIGQPA  276


>VFG036938(gb|WP_002224866) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis MC58]
Length=384

 Score = 47.8 bits (112),  Expect = 6e-06, Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 36/219 (16%)

Query  59   ALRKVDVGAQVSGQLKTLLVSIGDNVKKDQLLGVIDPD-------QAENQIKEVEATLME  111
            A R V V  Q  G ++ +L    D VKK  +L V+D D       +A+N++ +       
Sbjct  55   AGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELVQAVRQNRR  114

Query  112  LNAERQQAAAELKLARVTLARQQQ-------LAKTQAVSQQDL---------------DT  149
             NA   QA A++ L R  LAR Q        LA++ AVS ++L                 
Sbjct  115  QNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQAAVKAA  174

Query  150  AATEMAVKQARIGTIDAQ----IKRNRASLDTAKTNLEYTRIVAPMAGEVTQITTLQGQT  205
             A E + + A  G +  +    ++     L  A  NL+ T+I AP  G+V + +   GQ 
Sbjct  175  LAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQ  234

Query  206  VIAAQQAPNILTLADMSTMLVKAQVSEADVIHLRAGQKA  244
            V A   AP ++ +  +S + V A   E  + H++ GQ A
Sbjct  235  VAAG--AP-LMAVVPLSDVWVDANFKETQLRHMKIGQPA  270


>VFG036940(gb|WP_002247956) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis FAM18]
Length=390

 Score = 47.8 bits (112),  Expect = 6e-06, Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 36/219 (16%)

Query  59   ALRKVDVGAQVSGQLKTLLVSIGDNVKKDQLLGVIDPD-------QAENQIKEVEATLME  111
            A R V V  Q  G ++ +L    D VKK  +L V+D D       +A+N++ +       
Sbjct  61   AGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQAVRQNRR  120

Query  112  LNAERQQAAAELKLARVTLARQQQ-------LAKTQAVSQQDL---------------DT  149
             NA   QA A++ L R  LAR Q        LA++ AVS ++L                 
Sbjct  121  QNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQAAVKAA  180

Query  150  AATEMAVKQARIGTIDAQ----IKRNRASLDTAKTNLEYTRIVAPMAGEVTQITTLQGQT  205
             A E + + A  G +  +    ++     L  A  NL+ T+I AP  G+V + +   GQ 
Sbjct  181  LAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQ  240

Query  206  VIAAQQAPNILTLADMSTMLVKAQVSEADVIHLRAGQKA  244
            V A   AP ++ +  +S + V A   E  + H++ GQ A
Sbjct  241  VAAG--AP-LMAVVPLSDVWVDANFKETQLRHMKIGQPA  276


>VFG036948(gb|WP_002218708) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis M01-240149]
Length=384

 Score = 47.8 bits (112),  Expect = 6e-06, Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 36/219 (16%)

Query  59   ALRKVDVGAQVSGQLKTLLVSIGDNVKKDQLLGVIDPD-------QAENQIKEVEATLME  111
            A R V V  Q  G ++ +L    D VKK  +L V+D D       +A+N++ +       
Sbjct  55   AGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQAVRQNRR  114

Query  112  LNAERQQAAAELKLARVTLARQQQ-------LAKTQAVSQQDL---------------DT  149
             NA   QA A++ L R  LAR Q        LA++ AVS ++L                 
Sbjct  115  QNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQAAVKAA  174

Query  150  AATEMAVKQARIGTIDAQ----IKRNRASLDTAKTNLEYTRIVAPMAGEVTQITTLQGQT  205
             A E + + A  G +  +    ++     L  A  NL+ T+I AP  G+V + +   GQ 
Sbjct  175  LAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQ  234

Query  206  VIAAQQAPNILTLADMSTMLVKAQVSEADVIHLRAGQKA  244
            V A   AP ++ +  +S + V A   E  + H++ GQ A
Sbjct  235  VAAG--AP-LMAVVPLSDVWVDANFKETQLRHMKIGQPA  270


>VFG036941(gb|WP_002231691) (farA) fatty acid efflux system protein 
FarA [FarAB (VF0450) - Antimicrobial activity/Competitive 
advantage (VFC0325)] [Neisseria meningitidis 053442]
Length=384

 Score = 47.8 bits (112),  Expect = 7e-06, Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 36/219 (16%)

Query  59   ALRKVDVGAQVSGQLKTLLVSIGDNVKKDQLLGVIDPD-------QAENQIKEVEATLME  111
            A R V V  Q  G ++ +L    D VKK  +L V+D D       +A+N++ +       
Sbjct  55   AGRVVQVTPQKGGTVRKVLHDDTDAVKKGDVLAVLDDDNDVLAYERAKNELIQAVRQNRR  114

Query  112  LNAERQQAAAELKLARVTLARQQQ-------LAKTQAVSQQDL---------------DT  149
             NA   QA A++ L R  LAR Q        LA++ AVS ++L                 
Sbjct  115  QNAATSQAGAQVALRRADLARAQDDLRRRSALAESGAVSAEELAHARAAVSQAQAAVKAA  174

Query  150  AATEMAVKQARIGTIDAQ----IKRNRASLDTAKTNLEYTRIVAPMAGEVTQITTLQGQT  205
             A E + + A  G +  +    ++     L  A  NL+ T+I AP  G+V + +   GQ 
Sbjct  175  LAEESSARAALGGQVSLREQPAVQTAIGRLKDAWLNLQRTQIRAPADGQVAKRSVQVGQQ  234

Query  206  VIAAQQAPNILTLADMSTMLVKAQVSEADVIHLRAGQKA  244
            V A   AP ++ +  +S + V A   E  + H++ GQ A
Sbjct  235  VAAG--AP-LMAVVPLSDVWVDANFKETQLRHMKIGQPA  270



Lambda      K        H        a         alpha
   0.317    0.133    0.361    0.792     4.96 

Gapped
Lambda      K        H        a         alpha    sigma
   0.267   0.0410    0.140     1.90     42.6     43.6 

Effective search space used: 2819939130


  Database: VFDB_setB_pro.fas
    Posted date:  Apr 10, 2024  11:56 PM
  Number of letters in database: 13,298,383
  Number of sequences in database:  27,982



Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Neighboring words threshold: 11
Window for multiple hits: 40
